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The Wnt signaling pathway is critical to growth and development, and its 
dysregulation is implicated in myriad pathologies. Extensive research has been 
directed towards dissecting the signaling mechanisms of the various Wnt ligands in 
the context of normal cell growth and proliferation as well as in human diseases such 
as cancer. In contrast, the regulatory mechanisms governing the Wnt secretion 
pathway remain poorly characterized.  
There are two key regulators of the Wnt secretion pathway: an O-
acyltransferase Porcupine, which palmitoleates Wnts and the transmembrane protein 
Wntless (Wls), which transports Wnts to the plasma membrane. Wls is localized in 
the endoplasmic reticulum (ER), and cycles from the ER to the plasma membrane and 
back via the Golgi apparatus. Our overall aim was to fully characterize the 
physiological and biochemical parameters that underlie Wls regulation and the Wnt-
Wls interaction in the context of Wnt intracellular transport and secretion.  
Our laboratory has recently characterized a conserved ER-targetting motif that 
facilitates the retrograde transport of mammalian Wls from the plasma membrane 
(PM)(Yu et al., 2014). We thus sought characterize the in vitro endogenous 
localization of the Drosophila Wls homolog Evi in S2 Drosophila cells by examining 
the signaling activity of Evi mutants and investigating the subcellular fractionation 
patterns of endogenous Evi. However, we encountered several technical challenges 
during this project, and decided to focus our studies on exploring the modus operandi 
and regulation of human Wls. We identified putative hydrophobic Wnt-binding 
residues in Wls by examining the signaling activity and binding affinity of several 
Wls mutants. We extensively characterized the role of vesicular acidification in 
facilitating the dissociation of all mammalian Wnts from Wls in multiple cell lines, 
 vii 
and identified key histidine residues in Wls that may be contributing to its ‘pH-
sensing’ capacity as well as the pleiotropic effects of inhibiting vesicular acidification 
on Wnt secretion.  
Based on data from our collaborators, we characterized the biological role 
potential cytosolic interacting partner of Wls, and proceeded to generate an internally 
tagged Wls construct that is amenable to immunoprecipitation studies so as to identify 
novel interacting partners of Wls. Using CRISPR/Cas9 genome editing technology, we 
are currently engineering a homozygous Wls knockout HT1080 cell line for rigorous 
functional characterization of the Wnt-binding Wls mutants as well as the Wls histidine 
mutants. We also investigated whether Wls undergoes monoubiquitination by mutating 
putative ubiquitination residues and carrying out extensive functional analysis on these 
mutants so as to determine if monoubiquitination plays a regulatory role in the 
intracellular trafficking of Wls. By employing a multitude of experimental approaches, 
we aimed to unravel the diverse mechanisms governing the biological role of this key 
regulator of the Wnt secretion pathway. In doing so, we sought to lay solid biochemical 
foundations for the development of successful therapeutic intervention strategies 
targeting Wls to treat Wnt secretion-driven pathologies. 
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Chapter 1: Introduction & Specific Aims 
The Role of Wnt Signaling in Growth & Development   
The Wnt signaling cascade is involved in various growth and development 
processes. First identified in 1982 as the Wnt1 gene in induced breast tumors as a gene 
activated by the integration of the mouse mammary tumor proviral DNA (Nusse and 
Varmus, 1982), it was subsequently found to be highly conserved in mice and 
humans(van Ooyen et al., 1985). The significance of these secreted, cysteine-rich 
proteins(Fung et al., 1985)in triggering a highly-conserved developmental signal 
transduction cascade was made evident in subsequent studies in Drosophila , Xenopus 
and mice  models.  
In Drosophila, the fly Wingless (wg) gene, which was eventually found to be 
orthologous to the mouse Wnt1 gene(Rijsewijk et al., 1987), was found to direct 
segment polarity during larval development(Nüsslein-Volhard and Wieschaus, 1980). 
Further epistatic experiments in Drosophila resulted in the discovery of other key 
components in the Wnt signaling, namely porcupine, armadillo (mammalian β-
catenin), disheveled and zeste white 3(mammalian GSK3) (Noordermeer et al., 1994; 
Peifer et al., 1992; Siegfried et al., 1992). The critical role of Wnts in development 
was also demonstrated when Wnt over-expression in Xenopus early stage embryos led 
to duplication of body axis(McMahon and Moon, 1989). The diversity of the Wnt 
ligand genes was first discovered in fetal and adult mouse development(Gavin et al., 
1990).  
Genomic analysis in various organisms has led to the identification of 19 Wnt 
genes in most mammalian genomes, which can be further sub-classified into 12 
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conserved Wnt families(Clevers and Nusse, 2012). Wnt genes have been found in 
primitive metazoans including the sea anemone Nematostella vectensis (Kusserow et 
al., 2005)and sponges, but not in unicellular organisms, thereby suggesting an 
evolutionary link between the advent of multi-cellularity and the Wnt signaling 
pathway(Petersen and Reddien, 2009). The sheer variety and degree of conservation 
of these morphogens has initiated investigation into the various mechanisms by which 
they regulate growth and development.   
The Canonical Wnt Signaling Cascade 
Much scientific enquiry has been directed towards understanding the signaling 
mechanisms initiated by Wnt ligands and the subsequent effects on cell proliferation 
and differentiation. These mechanisms can be broadly classified into two main 
categories: the Wnt canonical signaling pathway and the Wnt non-canonical signaling 
pathway (comprising of the Wnt/calcium pathway and Wnt/Planar cell Polarity 
pathway) (Clevers and Nusse, 2012). These categories reflect the downstream effects 
of the signaling initiated by the different Wnt ligands; the canonical pathway results in 
the transcriptional activation of selected β-catenin-responsive genes whereas the non-
canonical pathways operate in a β-catenin-independent fashion. The traditional 
classification of Wnt ligands as specific initiators of either signaling category has come 
under recent controversy, as it has been demonstrated that cell-surface receptors to 
which these Wnt isoforms bind to are crucial in determining the type of downstream 
signaling(van Amerongen et al., 2008).  
Our laboratory’s research focuses primarily on the canonical Wnt signaling 
pathway, which is depicted in Figure 1a. This signaling pathway is dependent on 
changes in both the abundance and cellular localization of β-catenin. A highly versatile 
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protein, β-catenin is capable of participating in both cell signaling and adhesion. β-
catenin associates with α-catenin and E-cadherin in the plasma membrane to form 
adherens junctions that facilitate cell-cell adhesion and interaction(Ozawa et al., 1989).  
Its regulatory role in Wnt signaling was first discovered in Drosophila(Riggleman et 
al., 1990), where Armadillo mutants were found to be deficient in key structural 
components known as naked belts required for proper embryonic 
development(Wieschaus and Riggleman, 1987). The pleiotropic effects of β-catenin in 
mammalian development were characterized in conditional β- catenin mouse 
mutants(Grigoryan et al., 2008). Furthermore, mouse embryonic stem cells lacking β-
catenin are unable to differentiate and form a mesodermal germ layer, thereby 
extending the crucial role of β-catenin to stem cell differentiation(Lyashenko et al., 
2011).  
The evolutionarily conserved status, unique structural features and post-
translational modifications of β-catenin protein contribute to its pleiotropic mode of 
action(Valenta et al., 2012). Flanked by structurally flexible N and C-terminus 
domains, it possesses a rigid central region that acts as a scaffold for multiple protein 
interactions(Huber et al., 1997). Functional outputs of β-catenin are further guided by 
a variety of post-translational modifications it undergoes, including selective 
phosphorylation on serine, threonine and tyrosine sites, ubiquitination, acetylation and 
glycosylation(Valenta et al., 2012). Therefore, regulation of intracellular levels of β-
catenin is pivotal to the activation and regulation of canonical Wnt signaling.  
In the absence of Wnt ligand activation (Wnt OFF state, Fig. 1a), the levels of 
cytosolic β-catenin are kept relatively low by constitutive degradation by the β-
catenin destruction complex. This complex consists of several components: the tumor 
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suppressor scaffold proteins Axin and Adenoma Polyposis Coli (APC) as well as the 
serine-threonine kinases glycogen synthase kinase 3b (GSK3β) and casein kinase 1 
(CK1) and the multi-functional cytoplasmic protein Dishevelled (Dvl). Recently, it 
has been protein phosphatase 2A(PP2A) may also be part of this destruction 
complex(Kimelman and Xu, 2006); and well as the tumor suppressor protein WTX, 
which has been found to be mutated in pediatric kidney cancers(Major et al., 2007; 
Rivera et al., 2007). Both CK1 and GSK3β sequentially phosphorylate the N-terminus 
of cytoplasmic β-catenin at multiple serine and threonine residues. The hyper-
phosphorylated motif of β-catenin is recognized by a member of the F-box family of 
proteins known as β-TrCP, which also functions as part of an E3 ubiquitin ligase 
complex. As a result, the phosphorylated β-catenin undergoes poly-ubiquitination and 
is targeted for rapid degradation by the proteasome(Aberle et al., 1997).  
The interaction of Wnt ligands with target cells is mediated by their binding to 
a heterodimeric receptor complex at the plasma membrane comprising of the seven-
transmembrane protein Frizzled (FzD) and the single-pass transmembrane protein 
LRP6 (Fig. 1a, “Wnt ON”). The cysteine–rich domains of the ten mammalian Fzds 
interact promiscuously with multiple Wnts(Bhanot et al., 1996). Subsequent 
phosphorylation of LRP6 by CK1γ (Davidson et al., 2005)and GSK3 (Zeng et al., 
2005)results in the recruitment of Axin to the cytoplasmic tail of LRP6. Combined 
with the interaction of Dvl with the cytoplasmic portion of the Fzd protein(Chen et 
al., 2003), Wnt stimulation results in the dissociation of key components of the β-
catenin destruction complex.  
Cytoplasmic β-catenin is thus no longer phosphorylated and ubiquitinated, and 
instead accumulates and translocates to the nucleus. It binds to nuclear transcription 
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factor lymphoid enhancer-binding factor/T cell-specific (LEF/TCF) transcription 
factors(Behrens et al., 1996) and displaces the transcriptional repressor 
Groucho(Cavallo et al., 1998). A transcription complex comprising of LEF/TCF, β-
catenin, BCL9 (B-cell lymphoma 9 protein), Pygopus and histone modifier CBP 
[CREB (cAMP response element-binding)-binding protein] as well as other tissue-
specific transcription activators is formed, thereby initiating the transcription of Wnt 
responsive genes(Yu and Virshup, 2014).  
 
Figure 1a:  The canonical Wnt signaling pathway(adapted from Yu and Virshup, 
2014). When Wnt ligands are absent, cytoplasmic β-catenin is constitutively 
phosphorylated by the destruction complex comprising of GSK3, CK1, APC, Dvl 
and Axin, and is subsequently ubiquitinated by β-TrCP for proteosomal 
degradation. Wnt binding initiates the formation of the Frizzled-LRP heterodimeric 
receptor complex, which in turn sequesters key components of the destruction 
complex and results in the translocation of stabilized β-catenin to the nucleus and 
the initiation of transcription of Wnt-responsive genes.  
 6 
Wnt Canonical Signaling in Cancer 
Aberrant Wnt signaling has been implicated in myriad human pathologies, 
including developmental defects and tumourigenesis (Clevers and Nusse, 2012). 
Mutations in several components of the Wnt signaling pathway, notably β-catenin and 
the adenomatous polyposis coli protein complex, are directly linked to the onset of 
cancer (Kinzler and Vogelstein, 1996; Morin et al., 1997; Nishisho et al., 1991). 
Oncogenic β-catenin has been implicated not just in colon cancer, but also in melanoma 
(Rubinfeld et al., 1997)and various other solid tumor types(Reya and Clevers, 2005). 
Furthermore, hereditary mutations and loss-of-function mutations in Axin have been 
identified in colon carcinoma susceptibility and hepatocellular carcinomas 
respectively(Liu et al., 2000; Satoh et al., 2000). Inactivating mutations in Lef1, a 
member of the TCF family, have also been found in sebaceous skin tumors(Takeda et 
al., 2006). Downregulation of the E3 ubiquitin ligase ZNFR3, which regulates surface 
abundance of Frizzled receptors, has been observed in human gastric 
adenocarcinomas(Zhou et al., 2013). R-spondins have been recently characterized as 
being able to potentiate Wnt signaling, and recurrent gene fusions of this crucial Wnt 
signaling regulator have been identified in colon cancer(Seshagiri et al., 2012).  
The canonical Wnt signaling pathway, although fraught with complexity, is also 
rich in targets for therapeutic intervention. Small-molecule modulators have been 
developed to target the various players in the signaling pathway, including CK1, GSK3, 
Axin, TCF and β-catenin(Polakis, 2012; Yu and Virshup, 2014).  An alternative 
approach involves focusing on the upstream inhibition of the Wnt signaling pathway 
by developing monoclonal antibodies targeting Frizzled and LRP6(Ettenberg et al., 
2010; Gurney et al., 2012). A promising therapeutic intervention which is currently 
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undergoing clinical trials is a small molecular inhibitor of Porcupine, which is essential 
for Wnt secretion, and is hence a suitable target for Wnt-driven cancers (Liu et al., 
2013). In light of these developments, we seek to unveil new facets of the Wnt secretion 
pathway so as to expand therapeutic opportunities for effective intervention in the Wnt 
secretion pathway and successfully treat Wnt-dependent pathologies. 
 
Wnt Secretion 
Recently, efforts have been targeted towards elucidating the regulation of the 
secretion of Wnt ligands, which are approximately 40kDa in size, have several highly- 
conserved cysteine residues(Tanaka et al., 2002), and are highly-hydrophobic due to a 
post-translational lipid modification(Willert et al., 2003). Therefore, Wnts are thought 
to signal over short distances, and the mode of their extracellular transport has been a 
matter of much controversy. It has been proposed that Wnt are associated with other 
lipoprotein particles(Panáková et al., 2005), or with binding partners such as 
Swim(Gross et al., 2012), or carried to neighboring cells in exosomes(Zhang and 
Wrana, 2014)  as a means of extracellular transport. An alternative contact-dependent 
model has been suggested in Drosophila based on the interactions of Wg with adjacent 
Engrailed-positive cells(van den Heuvel et al., 1989) and short-range signaling in the 
neuromuscular junction(Korkut et al., 2009). Recent live-cell imaging studies have 
indicated the presence of Wnt ligands on the tips of specialized filopodia-like 
extensions known as cytonemes(Stanganello et al., 2015). The latest model of 
cytoneme-mediated Wnt stimulation of adjacent cells has gained significant traction, as 
it elegantly explains the short-range Wnt signaling activity observed in adult stem cell 
niches(Sato et al., 2011). Our laboratory has recently demonstrated that Wnt ligands in 
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the intestinal stem cell niche may be supplemented by stromal production in the absence 
of epithelial Wnts(Kabiri et al., 2014).   
Post-translational modifications on Wnts such as palmitoleation and 
glycosylation have been shown to be essential for their extracellular secretion. 
Glycosylation is a common feature of secreted proteins, and is essential for proper Wnt 
secretion(Komekado et al., 2007). It has also been demonstrated recently that variations 
in glycosylation patterns between different Wnts determines apical versus basolateral 
secretion(Yamamoto et al., 2013). Upon being synthesized in the endoplasmic 
reticulum (ER), Wnts are palmitoleated by the membrane-bound, highly conserved O-
acyltransferase Porcupine. The lipid modification catalyzed by Porcupine occurs at a 
unique site on Wnt the serine 209 residue (Coombs et al., 2010; Janda et al., 2012a), 
which corresponds to the serine 239 residue in Drosophila Wg (Herr and Basler, 2012). 
The critical role played by Porcupine in Wnt secretion is illustrated by specific 
mutations in Porcupine being associated with the X-linked dominant genetic disease 
focal dermal hypoplasia (Proffitt and Virshup, 2012). Extensive characterization of this 
enzyme by our laboratory has demonstrated the indispensible role of Porcupine in 
palmitoleating all Wnts and thereby priming them for secretion, as knocking out or 
inhibiting Porcupine completely ablates Wnt secretion(Najdi et al., 2012; Proffitt and 
Virshup, 2012). Porcupine may also be involved in a Wnt pathway-independent 
capacity in other signaling pathways that contribute to cell growth and proliferation 
(Covey et al., 2012). Palmitoleation at Ser209 on Wnt3a by PORCN facilitates the 
interaction between Wnt3a and the lipocalin-like domain of Wntless (Wls) (Coombs et 
al., 2010).  
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Wntless: The wings beneath all Wnts 
Wls is an evolutionarily conserved transporter indispensible for the intracellular 
trafficking and extracellular secretion of several Wnts (Das et al., 2012a). Wls, also 
known as Evi/Sprinter in Drosophila, was first discovered in 2006 through both in vivo 
genetic screening in Drosophila and in vitro RNAi screening in insect S2R+ cells as 
being the causative agent of Wnt loss-of-function phenotypes (Bartscherer et al., 2006; 
Bänziger et al., 2006). Wls has been classified as a putative G-protein coupled receptor 
based on amino acid sequence analysis that predicts the presence of an intracellular C-
terminus, seven or eight transmembrane domains and a lengthy N-terminal domain 
(Das et al., 2012a; Jin et al., 2010). Like most GPCRs, Wls also undergoes N-linked 
glycosylation, but the biological implication of this modification is still unclear (Jin et 
al., 2010).  
Several studies have examined the subcellular localization and intracellular 
localization of Wls. It was previously proposed that Wls is localized primarily to the 
Golgi apparatus, and recycles from the plasma membrane (PM) upon endocytosis via 
retrograde transport by the retromer complex and sorting nexins to the Golgi 
(Bartscherer and Boutros, 2008; Belenkaya et al., 2008; Harterink and Korswagen, 
2012; Yang et al., 2008). Wls also bears a conserved endocytosis motif in its third 
intracellular loop that facilitates its internalization through the proposed recruitment of 
the clathrin adapter protein 2 complex (Gasnereau et al., 2011).  
 Recent studies in our laboratory have demonstrated that the observed Golgi 
localization of Wls is an experimental artifact of tagging the C-terminus of Wls and 
endogenous Wls instead exhibits ER localization due to the presence of a conserved 
KxxQx ER-targeting motif. Wls traffics to the Golgi from the ER in COPII-coated 
vesicles, and then to the PM in secretory vesicles, and finally cycles back to the ER. 
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Wls is thus the only known ER-PM-ER cycling integral membrane protein. ERGIC2 is 
responsible for retrograde trafficking of Wls from the Golgi to the ER, which occurs in 
COP1-coated vesicles. The formation of these vesicles is mediated by the small GTPase 
ARF (Yu et al., 2014). The revised Wnt secretion pathway depicted in Figure 1b 
encapsulates these seminal contributions.   
 
 
Figure 1b: The revised Wnt secretion pathway(adapted from Yu and Virshup, 
2014). Endogenous Wls is found primarily in the endoplasmic reticulum (ER), and 
binds to Wnts that have been pamitoleated by the enzyme Porcupine. The Wnt-Wls 
complex is then transported to the plasma membrane in an anterograde fashion. Upon 
the dissociation of Wnt bound to Wls, the latter is endocytosed by the retromer 
complex and then undergoes retrograde transport to the ER in COP1 vesicles and 
assisted by Arf proteins and ERGIC2. 
 
Several investigations have highlighted the importance of this carrier protein in 
several developmental processes and Wnt-secretion related pathologies. Wls has been 
shown to regulate tooth elongation and dentin opposition(Bae et al., 2015), and the 
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onset of psoriasis-like dermatitis has been observed upon the loss of epidermal 
Wls(Augustin et al., 2013). It is essential for the development of pulmonary 
vasculature, especially endothelial differentiation as well as and peripheral lung 
morphogenesis(Cornett et al., 2013). It has also been implicated in the regulation of 
osteogenesis and chondrogenesis in skeletal development(Maruyama et al., 2013), and 
also regulates bone mass through Wnt secretion in mature osteoblasts(Zhong et al., 
2012). In the context of cancer, the prominence of Wls as a critical regulator of Wnt 
secretion and a predictive biomarker has been steadily increasing. Over-expression of 
Wls promotes cell proliferation in astrocytic gliomas(Augustin et al., 2012) and in Wnt-
driven breast cancers(Lu et al., 2015). Wls over-expression has also been associated 
with poor prognosis for B-cell precursor acute lymphoblastic leukemia(Chiou et al., 
2014). Our laboratory has also found Wls over-expression to strongly correlate with 
HER2 over-expression in gastric, ovarian and breast cancer(Stewart et al., 2015).  
 
Central Objective 
Despite the growing body of literature devoted to understanding the role of Wls 
in human development and disease and Wls intracellular trafficking in the context of 
Wnt secretion, relatively little is known about the mechanisms regulating the Wls-Wnt 
interaction and the biological activity of Wls. Therefore, our overarching aim was to 
fully characterize the physiological and biochemical parameters that underlie Wls 
regulation and the Wnt-Wls interaction in the context of Wnt intracellular transport and 








Specific Aim 1: Characterizing the endogenous localization of Drosophila Evi in S2 
cells. 
 Our laboratory has successfully demonstrated that endogenous human Wls is 
localized primarily in the endoplasmic reticulum (ER), and possesses a conserved ER-
targetting motif that facilitates its retrograde transport from the plasma membrane 
(PM)(Yu et al., 2014). Since this ER-targeting motif is conserved in Drosophila Evi, 
we sought to verify if this phenomenon holds true in S2 Drosophila cells. We 
generated point mutants in the ER-targeting motif of Evi, and carried out a 
comparative analysis of their Wg signaling capacity. We also investigated the cellular 
localization of untagged Evi and Evi-GFP using subcellular fractionation techniques. 
Verification of Evi intracellular localization would further confirm Wls as a bona fide 
novel ER-PM-ER cycling carrier protein.  
 
Specific Aim 2: Determining the biochemical basis of the Wnt-Wls interaction  
The Wnt-Wls interaction requires palmitoleation of the Wnts at the highly 
conserved serine residue corresponding to Ser209 in Wnt3a and Ser239 in Drosophila 
Wg (Coombs et al., 2010; Herr and Basler, 2012). A lipocalin-like domain at the N-
terminus of Wls is necessary for its association with Wnt1, 3 and 5a (Fu et al., 2009). 
The binding dynamics of Porcupine to Wnt 3a were recently characterized (Rios-
Esteves et al., 2014). However, the amino acid residues of Wls stabilizing the Wnt-Wls 
interaction are not known. Using extensive site-directed mutagenesis on highly 
conserved hydrophobic residues in Wls, we identified the residues critical for the Wls-
Wnt interaction via immunoprecipitation assays, and characterized their Wnt signaling 
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capabilities accordingly. Characterizing the key residues of Wls involved in the Wnt-
Wls interaction is an important step towards developing targeted small molecule 
competitive antagonists (Arkin and Wells, 2004) that may inhibit Wnt binding to Wls. 
 
Specific Aim 3: Investigating the role of intracellular pH changes in the dissociation 
of Wnts from Wls 
Previous studies have indicated that perturbing intracellular pH impedes proper 
Wnt secretion (Coombs et al., 2010). We hypothesized that pH changes are an integral 
feature of intracellular Wnt trafficking and facilitate the dissociation of Wnts from Wls. 
We analyzed the differences in Wnt binding affinity of Wls following the mutation of 
key conserved histidine residues in Wls so as to examine the biochemical mechanism 
governing the pH-sensitive dissociation of Wnts from Wls. Candidate Wnts tagged with 
pHluorin2 as well as the Wls-pHluorin2 fusion protein was generated to validate the 
occurrence of a continuous pH gradient during intracellular Wnt trafficking via live cell 
imaging. Moreover, we investigated the effects on inhibiting vesicular acidification on 
the secretion of multiple Wnts in various cell lines, and found a surprising degree of 
variation. Elucidating the exact mechanistic basis of intracellular pH changes on Wnt 
secretion will lay the groundwork for testing proton-pump inhibitors such as 
esomeprazole in targeted combination chemotherapy to improve treatment outcomes 
for Wnt-driven cancers (McCarty and Whitaker, 2010). 
 
Specific Aim 4: Characterizing novel interacting partners of Wntless relevant to the 
Wnt secretion pathway 
 Wls has been shown to interact with several proteins regulating its trafficking 
and endocytosis along the Wnt secretory pathway (Das et al., 2012a; Yu et al., 2014). 
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Hence, we hypothesized that Wls interacts with proteins yet unknown, and these 
interactions may exert a regulatory role on Wnt secretion. Mass spectrometry data from 
our collaborators had identified several cytosolic proteins as candidate Wls interactors, 
thereby supporting our hypothesis. The impact of knocking down these candidate 
interactors on Wnt signaling with specific silencing RNAs (siRNAs) was assessed 
using Wnt-responsive luciferase reporter assay. We also generated and validated an 
internally tagged functional Wls construct to be used for further immunoprecipitation 
experiments so as to identify potential interacting partners through mass spectrometric 
analysis.  
 
Specific Aim 5: Engineering a Wls knockout cell line using CRISPR/Cas9 genome 
engineering technology 
Our laboratory has generated a HT1080 Porcupine-null cell line using zinc 
finger nucleases to determine the phenotypic consequences of knocking out Porcupine 
on Wnt secretion(Proffitt and Virshup, 2012).  The advent of CRISPR/Cas9 genome 
editing technology has significantly improved the efficiency of the genetic engineering 
process(Mali et al., 2013a). Using this technology, we sought to engineer a Wls 
knockout cell-line to be deployed for rigorous functional characterization of the Wnt-
binding Wls mutants as well as the Wls histidine mutants.   
 
Specific Aim 6: Investigating the role of monoubiquitination in the regulation of Wls 
Monoubiquitination has been shown to regulate the endocytosis of cell-surface 
receptors in several signaling pathways(Haglund et al., 2003). Based on proteome date 
from PhosphoSite®, we investigated whether Wls undergoes monoubiquitination by 
mutating putative ubiquitination residues in Wls and carrying out extensive functional 
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analysis on these mutants. We intend to follow up our preliminary findings with 
conclusive mass spectrometric analysis of purified Wls. 
By undertaking the extensive characterization of the Wnt-Wls interaction and 
the various means by which Wls activity and trafficking might be regulated, we seek to 
expand the current model of the Wnt secretion pathway. We also intend to lay the solid 
biochemical foundations for the development of successful therapeutic intervention 




CHAPTER 2: General Materials and Methods 
In this section, general materials and methods that are pertinent across chapters 
will be elaborated upon.  Other specific methods and materials used will be described 
in the methods’ sections of their respective chapters.  
General Chemicals and Reagents 
Phosphate Buffered Saline (PBS), Tris Buffered Saline (TBS) buffer, Tris-
Acetate-EDTA (TAE) buffer, Tris Glycine-Sodium Dodecyl Sulfate (TG-SDS) 
buffer, glycerol, Luria-Bertani (LB) broth and agar, agarose and other reagents were 
purchased from 1st Base (Singapore). Bovine serum albumin (BSA), and OptiPrep™ 
density gradient medium were purchased from Sigma-Aldrich. Protease inhibitor 
cocktail tablets were from Roche. Monensin was purchased from Sigma-Aldrich, 
bafilomycin was from A.G Scientific and MG132 was from Selleck Chemicals. The 
Porcupine inhibitor C59 was synthesized by Experimental Therapeutics Center 
(Singapore).  
DNA Techniques  
Primers  
Primers used for sequencing, polymerase chain reactions and cloning were 
synthesized by either 1st Base (Singapore) or AITbiotech (Singapore). A list of PCR 
primer sequences and siRNA targeting sequences can be found in Appendix I.  
DNA Visualization 
DNA was visualized via agarose gel electrophoresis using 0.8-1.2% (w/v) 
agarose gels cast in TAE buffer containing SYBR® Safe DNA gel stain (Invitrogen) 
and TAE buffer as running buffer at an average voltage of 100V. DNA samples were 
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mixed with 6× DNA loading buffer (Fermentas) and loaded onto the agarose gel 
along with either 1 kilo base (kb) or 100 base pair (bp) DNA ladder (Fermentas). A 
Bio-Rad Gel Doc UV trans-illuminator was used to detect the DNA bands. For clearer 
resolution of DNA bands of similar size, 10% polyacrylamide gels cast in TAE buffer 
were used instead, and these gels were stained with ethidium bromide.  
Polymerase chain reactions (PCR) 
For cloning purposes, PCR reactions were carried out in a thermal cycler (Bio-
rad) using Platinum® Taq DNA polymerase High Fidelity (Invitrogen). A typical 50 
µl reaction consisted of: primers at 0.2 µM each, dNTP mix at 0.2 mM (Promega), 2 
mM of magnesium sulphate (MgSO4), 1 unit of Platinum® Taq DNA polymerase 
High Fidelity (0.2 µl), 100 ng of DNA template, 5 µl of 10× High Fidelity PCR 
reaction buffer, and sterile distilled water to make up the volume. The PCR profile 
was: initial denaturation at 94°C for 2 min, followed by 30 cycles of denaturation at 
94°C for 30 sec, annealing at 55°C for 30 sec and extension at 68°C for 1 min per kb 
of PCR product, with a final extension at 68°C for 10 min.  
For screening purposes, PCR reactions were carried out in the same thermal 
cycler (Bio-rad) using GoTaq® DNA polymerase (Promega). A typical 25 µl reaction 
consisted of: primers at 0.2 µM each, dNTP mix at 0.2 mM (Promega), 1 unit of 
GoTaq® DNA polymerase (0.2 µl), 50 ng of DNA template, 5 µl of 5× GoTaq® 
Green PCR reaction buffer, and sterile distilled water to make up the volume. The 
PCR profile was: initial denaturation at 95°C for 2 min, followed by 30 cycles of 
denaturation at 95°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C 




Restriction Endonuclease-based Cloning  
Restriction enzyme digests were performed using the appropriate buffers 
specified by the manufacturers (New England Biolabs). For verifying plasmid size 
and integrity, 500 ng of DNA was digested with 0.2 µl of restriction enzymes at 37oC 
for 4 hours in a 10 µl reaction. For digesting vector plasmids for cloning, 2 ug of 
DNA was digested with 1 µl of each restriction enzymes and 1X BSA at 37oC 
overnight in a total reaction volume of 50 µl.  For digesting purified PCR products for 
cloning, 20 µl of the PCR product was digested with 1 µl of each restriction enzyme 
and 1X BSA at 37oC overnight in a total volume of 50 µl reaction.   
Gel Extraction and PCR Clean Up 
 Digested DNA fragments from agarose gels were purified using the Macherey-
Nagel (MN) NucleoSpin extract II kit according to the manufacturer's instructions. 
Briefly, 1 volume of PCR product was mixed with 2 volumes of buffer NT1. For gel 
extraction, 100 mg of agarose with DNA was dissolved in 200 µl of the same buffer. 
The mixture was then loaded onto the silica column and spun at 11,000 ×g for 1 min. 
The column was further washed once with 600 µl of buffer NT3 and dried by 
spinning at 11,000 ×g for 2 minutes. The DNA was eluted with 30 µl of distilled 
water.  
Ligation & Transformation 
 T4 DNA ligase and T4 DNA ligase buffer from New England Biolabs were used 
for DNA ligation according to manufacturer’s instructions. The molar ratio of cut 
vector to insert used was either 1 to 3 or 1 to 10. Briefly, 50 ng of digested and 
purified vector was mixed with appropriate amount of PCR insert, 2 µl of 5× T4 DNA 
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ligase buffer and 1 µl of T4 DNA ligase in a 10 µl reaction. The mixture was 
incubated at 16oC overnight prior to transformation.   
For transformation, chemically competent bacterial strains such as TOP10, DH5α 
and Stbl3 were used depending on the properties of the vector backbone. Briefly, 10 
µl of the ligation reaction was added to 100 µl of competent cells and incubated on 
ice for 30 minutes, followed by heat-shock at 42oC for 1 minute and incubation on ice 
for 2 minute. For recovery, 900 µl of antibiotic-free LB medium was added to each 
tube, and this mixture was incubated for 1 hour at 37oC before plating the bacteria on 
LB-agar plates of suitable antibiotic resistance.  
QuikChangeTM Site-directed mutagenesis 
PCR primers (Refer to Appendix for a list of PCR primer sequences) were 
designed according to the manufacturer’s instructions (QuikChangeTM site-directed 
mutagenesis kit, Stratagene). Briefly, 50 ng of plasmid DNA template was used for 
PCR with 5 µl of 10× reaction buffer, 0.3 µM of each primer, 1 µl of dNTP mix and 1 
µl of the proofreading PfuTurbo DNA polymerase (2.5 U/µl) (Stratagene), followed 
by distilled water to make a final volume of 50 µl. PCR reactions were carried out in a 
thermal cycler (Bio-rad) according the following program: initial denaturation at 95°C 
for 30 sec, followed by 18 cycles of denaturation at 95°C for 30 sec, annealing at 
55°C for 1 min and extension at 68°C for 1 min per kb of plasmid length. After PCR, 
1 µl of Dpn I restriction enzyme (10 U/µl) was added directly to the mixture and the 
tubes were immediately incubated at 37°C for 2 hours to digest methylated parental 
DNA. For transformation, 5 µl of Dpn I–treated sample was added to 50 µl of DH5α, 
and the procedure was carried out as mentioned above. 
  
 20 
Preparation of plasmid DNA  
Small-scale plasmid preparations were performed using a MN NucleoSpin mini-
prep kit according to manufacturer’s instructions. Briefly, the bacterial cells were 
harvested by centrifugation (11,000 ×g for 5 min at 4°C) and the cell pellet was 
resuspended in RNase A-containing resuspension buffer A1. The alkaline lysis buffer 
A2 was used to lyse pelleted cells for 5 min, followed by the addition of acidic buffer 
A3 to neutralize and stop further lysis. The high salt concentration in buffer A3 
caused bacterial proteins, chromosomal DNA and cellular debris to precipitate. This 
slurry was subjected to high-speed centrifugation for 10 minutes at 11,000 ×g. The 
resultant cleared plasmid supernatant was loaded into a spin column where the silica 
membrane can bind to plasmid DNA. The column was washed with 70% ethanol and 
the purified plasmid was eluted in 50 µl of distilled water.  
Large-scale endotoxin-free plasmid DNA for transfection was prepared using the 
MN NucleoBond Xtra Midi EF kit according to manufacturer’s instructions. The 
procedure is similar up to the DNA elution step. Upon elution in the elution buffer, 
the plasmid DNA was precipitated by the addition of 0.7 volume of endotoxin-free 
isopropanol (Sigma-Aldrich) and loaded onto the MN NucleoBond finalizer for 
concentrating and desalting purposes. After washing with 70% ethanol, the finalizer 
was air-dried by pumping air through using a syringe. The plasmid DNA was eluted 
in a suitable volume (500 µl -800 µl) endotoxin-free TE buffer.  
DNA Sequencing 
DNA sequencing was carried out by either 1st Base or AITbiotech. 
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RNA Techniques  
RNA isolation 
Total RNA was extracted from cells using Qiagen RNeasy kits according to 
manufacturer’s instructions. Briefly, the cells were lysed directly in buffer RLT and 
then homogenized using the QIAshredder (Qiagen). One volume of 70% ethanol was 
added to the homogenized lysates prior to loading into the RNeasy mini column. The 
column was washed once with buffer RW1 and twice with buffer RPE (containing 
ethanol). High-speed centrifugation was performed to dry the column, and RNA was 
eluted with nuclease-free water. RNA concentration was determined by NanoDrop 
2000 spectrometry (Thermo Scientific).  
Reverse transcription of total RNA 
Reverse transcription of total RNA was performed using iScript™ cDNA 
synthesis kit (Bio-Rad) according to the manufacturer’s instructions. Briefly, 1 µg of 
extracted total RNA, 4 µl of 5× reaction mix pre-blended with oligo (dT) and random 
hexamer primers, and 1 µl of iScript reverse transcriptase were mixed together and 
topped up with nuclease-free water to a final volume of 20 µl. The reaction was 
carried out with an initial 5 min incubation at 25°C, followed by incubation at 42°C 
for 30 min. Finally, a denaturation step was performed at 85°C for 5 min and the 
cDNA was stored at -20°C. 
Quantitative real-time PCR (RT-PCR/qPCR) 
A list of real-time PCR primer sequences can be found in Appendix. Quantitative 
real-time PCR was performed using SsoFast™ EvaGreen® supermix (Bio-Rad) 
according to the manufacturer’s instructions. Briefly, 2 µl of synthesized cDNA, 10 µl 
of 2× SsoFast EvaGreen supermix, and 0.5 µM of forward and reverse primers were 
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mixed together and topped up to a final volume of 20 µl with nuclease-free water. 
Each reaction was carried out in duplicate. Thermal cycling was performed on the 
Bio-Rad iCycler iQ5 PCR thermal cycler as follows: initial step with 30 sec at 95°C 
to activate the enzyme, followed by 40 cycles of 5 sec at 95°C and 10 sec at 55°C. 
The machine was programmed to generate a melting curve after each amplification 
step in which the temperature was raised from 65°C to 95°C. Results were analyzed 
using iQ5 Optical System software (Bio-Rad). 
 
Cell Culture and Transfection Techniques 
Cell culture 
Cell lines used from the American Type Culture Collection (ATCC) include:  
HeLa (ATCC CCL-2, human cervical adenocarcinoma epithelial cell line) and 
HT1080 (ATCC CCL-121, human fibrosarcoma epithelial cell line). The STF reporter 
cell line (HEK 293 cells with a stably integrated firefly luciferase gene downstream of 
eight tandem repeats of the LEF/TCF responsive elements) was a generous gift from 
Kang Zhang (University of California San Diego, La Jolla, CA) (Xu et al., 2004). The 
STF3A cell line containing an additional stably integrated mouse WNT3A expression 
plasmid was a gift from Karl Willert, University of California San Diego, La Jolla, 
CA. The S2 Drosophila cells used were a gift from Dr. Katsutomo Okamura 
(Temasek Life Sciences Laboratory, Singapore).  
All human cell lines mentioned above were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) with L-glutamine and HEPES (Nacalai Tesque) 
supplemented with 10% (v/v) fetal bovine serum (FBS, HyClone, Thermo Scientific), 
penicillin/streptomycin (Gibco, Invitrogen) and sodium pyruvate (Sigma-Aldrich). 
 23 
Cells were cultured in T75 tissue culture flasks at 37°C and 5% CO2, and passaged 
every 3-4 days with trypsin-EDTA (Gibco, Invitrogen).   
The S2 Drosophila cells were cultured in Schneider’s Drosophila media 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum (FBS, HyClone, 
Thermo Scientific) and 1% (v/v) L-glutamine. These non-adherent cells were cultured 
in T75 tissue culture flasks at 37°C and 5% CO2, and passaged every 3-4 days when 
they attained a density of 1 million cells/ml.  
Transient DNA transfection  
Transfections were carried out in the following formats with the corresponding 
amounts of total plasmid DNA transfected: 100mm plate (5 µg DNA), 60 mm plate (2 
µg DNA), 12-well plate (1 µg DNA) and 24-well plate (500 ng DNA). The following 
transfection reagents were used transient DNA transfections: Lipofectamine 2000 
transfection reagent (Invitrogen) was used for HeLa and HT1080 cells, TurboFect 
transfection reagent (Fermentas) was used for STF cells, and Effectene transfection 
reagent (Qiagen) was used for S2 Drosophila cells. DNA was added into Opti-MEM® 
reduced serum medium (Gibco, Invitrogen) in one tube. Appropriate amount of 
transfection reagent (DNA to transfection reagent ratio is 1 µg to 2 µl) was added into 
another tube containing Opti-MEM® reduced serum medium and incubated at room 
temperature for five minutes. The two tubes were then mixed together and the mixture 
was further incubated at room temperature for twenty minutes. The transfection 
mixture was added drop-wise onto the cells cultured with DMEM medium containing 
5% FBS and incubated for 4-6 hours, and then replaced with DMEM supplemented 
with 10% FBS and antibiotics. For S2 Drosophila cells, EC buffer from the Effectene 
transfection kit was used instead of Opti-MEM® reduced serum medium, and 
Schneider’s supplemented media described above was used instead of DMEM.  
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siRNA transfection  
Non-targeting control siRNA and WLS siRNAs purchased from Dharmacon and 
SABio (Singapore) respectively. For siRNA transfection, Dharmafect transfection 
reagent 1 was used according to the manufacturer’s instructions (Dharmacon). 
Briefly, 2 µM of siRNA was diluted in Opti-MEM® medium and incubated at room 
temperature for 5 minutes, while a corresponding amount of Dharmafect transfection 
reagent 1 was diluted in Opti-MEM® medium in a separate tube. These two solutions 
were mixed and incubated at room temperature for an additional 20 minutes before 
adding drop-wise to the cells. 
 
Protein Techniques 
Lysate preparation from cultured cells 
Cultured cells were rinsed once with cold PBS before being lysed in cold HEPES 
lysis buffer [50 mM HEPES, pH 7.4, 150 mM NaCl, 0.6% IGEPAL CA-630 (Sigma-
Aldrich), 1 mM EDTA and protease inhibitor cocktail (1 tablet in 50 ml of buffer, 
Roche)]. Whole cell lysate was collected by scraping cell culture plates with a cell 
scraper. The lysate were then clarified by centrifugation at 11,000 ×g for 10 min at 
4°C and the supernatant was collected and used for either analysis or 
immunoprecipitation. Alternatively, cells were lysed directly in 4% SDS and the 
lysate was repeatedly passed through a 22-gauge syringe to shred viscous genomic 
DNA, followed by boiling at 95C for 5 minutes.  
SDS-PAGE Analysis of Protein 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
used to analyze protein expression with a Mini-PROTEAN® Tetra cell (Bio-Rad). 
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The polyacrylamide gels used were 1.5 mm in thickness. Protein samples were 
denatured by mixing with 4× sample buffer (250 mM Tris-HCl, pH 6.8, 8% (w/v) 
SDS, 20% β-mercaptoethanol, 40% glycerol and 0.2% (w/v) bromophenol blue) and 
boiling at 95°C for 5 min. The denatured protein samples were then run on 10% SDS-
PAGE gels in Tris glycine-sodium dodecyl sulfate (TG-SDS) electrophoresis running 
buffer (1st Base). The separated proteins were subsequently visualized by 
immunoblotting, Coomassie staining and/or silver staining.  Protein molecular 
weights were estimated using molecular size marker Precision Plus Protein 
WesternC™ Standards (Bio-Rad) for immunoblotting, PageRuler Pre-stained Protein 
Ladder  (Fermentas) for Coomassie staining and Precision Plus Standard Unstained 
(Biorad) for silver staining.  
Immunoprecipitation 
Transfected cells were washed once with PBS and lysed in Tris lysis buffer (50 
mM Tris, 150 mM NaCl, 1 mM EDTA, 1% IGEPAL CA-630, 0.25% sodium 
deoxycholate, pH 7.4) supplemented with complete protease inhibitor cocktail and 
1mM dithiothreitol (Gold Biotech). Cell debris was removed by centrifugation at 
11,000 ×g for 10 min at 4°C. 1-2 μg of the appropriate antibody was added to 500 μg 
of total cell lysate protein for each immunoprecipitation. The reactions were 
incubated overnight at 4°C with gentle agitation. The next day, 20 μl of protein A/G 
plus agarose beads (Santa Cruz Biotechnology) were added to bind to the 
immunocomplexes for an additional 2 hours. The pelleted immunoprecipitates were 
washed thrice in the lysis buffer and the bound proteins were eluted with 60 µl of 2× 




Western transfer and immunoblotting 
Following SDS-PAGE separation, the proteins were electrophoretically 
transferred onto Immobilon FL membranes (Millipore) that were pre-activated with 
methanol. Wet transfer was carried out in transfer buffer containing 25 mM Tris, 192 
mM glycine, and 20% methanol for 1 hr at 100V at 4°C using the mini Trans-Blot® 
cell apparatus (Bio-Rad). After the transfer, the membranes were incubated in 
blocking buffer [TBS containing 5% (w/v) non-fat milk (Bio-Rad) and 0.5% (v/v) 
polyoxyethylenesorbitan monolaurate (TWEEN® 20, Sigma-Aldrich)] for 40 min at 
room temperature. The membranes were then incubated at cold room with primary 
antibody (diluted in TBS-TWEEN containing 3% BSA) for overnight. Unbound 
antibodies were removed by washing three times in wash buffer (TBS containing 
0.5% TWEEN® 20). Membranes were then incubated with secondary antibodies 
depending on the experimental conditions.  
In some experiments, membranes were incubated with secondary antibodies 
conjugated to horseradish peroxidase (HRP) (1 in 10,000 dilution in TBS-TWEEN 
containing 5% (w/v) non-fat milk) for 60 min at room temperature and then washed in 
wash buffer thrice. The protein standards were visualized by adding Precision 
Protein™ StrepTactin-HRP conjugate (Bio-Rad) into the secondary antibody solution. 
Membranes were then developed using Immuno-Star™ WesternC™ 
Chemiluminescence Kit (Bio-Rad). ImageQuantTM Imager (GE Healthcare) was used 
to capture and process the gel images. In other experiments, membranes were 
incubated with fluorescent secondary antibodies conjugated to Dylight680 or 
Dylight800 (1 in 10,000 dilution in TBS-TWEEN containing 5% (w/v) non-fat milk) 
for 60 min at room temperature and then washed in wash buffer thrice. These 
membranes were then imaged using the Odyssey TM Infrared Imager. 
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Antibodies and immunoprecipitation reagents 
Primary antibodies used for the various experiments were obtained from a variety 
of commercial and non-commercial sources. The Wntless mouse monoclonal 
antibodies and the Wntless C-terminus polyclonal rabbit antibodies were generated 
and purified by Dr. Yu Jia in our laboratory. The FLAG antibody against FLAG 
epitope (FLAG M2) was purchased from Sigma-Aldrich and anti-MYC (clone 9E10) 
antibody and anti-HA (Y11) rabbit polyclonal antibody was from Santa Cruz 
Biotechnology. V5 mouse antibody was from Invitrogen. Rabbit calnexin (C5C9) 
antibody was from Cell signaling, while Drosophila calnexin, Drosophila syntaxin 16 
and β-tubulin antibodies were from Abcam. The Drosophila Anti-Evi rabbit 
antibodies were a kind gift from Dr. Vivian Budnik’s laboratory, USA. Mouse 
monoclonal anti-GFP antibody was from Roche. Anti-WNT3A mouse monoclonal 
antibody was a generous gift from Shinji Takada (Okazaki Institute for Integrative 
Bioscience and National Institute for Basic Biology, Okazaki, Japan). Protein A/G 




HeLa cells were seeded onto coverslip (No. 1.5 coverslips with 0.17 mm 
thickness) the day before transfection such that they would be about 60% - 80% 
confluent the next day. They transfected with respective plasmids using 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. Forty-
eight hours post-transfection, cells were fixed with 4% paraformaldehyde at room 
temperature for 15 min. Alternatively, cells were fixed by methanol for 10 min at -
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20oC. Cells were then permeabilized with 0.1% Triton X-100 at room temperature for 
10 min, before blocking the non-specific binding sites with 5% goat serum in PBS. 
Respective primary antibodies were diluted in 1% goat serum in PBS and added onto 
the coverslips to allow overnight incubation at 4oC. The next day, after removing the 
primary antibody, Alexa Fluor®–conjugated secondary antibodies (1:2000, Molecular 
Probes from Invitrogen) were added and incubated at room temperature for 30 min. 
Coverslips were mounted onto glass slides using VECTASHIELD mounting medium 
with DAPI (Vector Laboratory). The images were taken using either Zeiss LSM710 
confocal microscope or super resolution Nikon N-SIM microscope. 
Fluorescence Assay Techniques 
Luciferase assay 
Transfected cells were washed once with PBS before lysis in 100 µl of Reporter 
Lysis Buffer (Promega) supplemented with complete protease inhibitor cocktail 
(Roche). Cell debris was then removed by centrifugation at 11,000 ×g for 5 min at 
4°C. 20 µl of the cleared lysate was mixed with 50 µl of luciferase assay reagent 
(Promega).  Luminescence was measured using Tecan Infinite 200 microplate reader 
(Thermo Scientific) with one-second integration time. 
mCherry Fluorescence assay 
This assay was carried out to normalize luciferase data to adjust for variations 
in transfection efficiency. Transfected cells were washed once with PBS before lysis 
in 100 µl of Reporter Lysis Buffer (Promega) supplemented with complete protease 
inhibitor cocktail (Roche). Cell debris was then removed by centrifugation at 11,000 
×g for 10 minutes at 4°C. The fluorescence of 20 µl of the cleared lysates was 
measured at 585 nm.  
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Spectrophotometry Assay Techniques 
BCA Protein Estimation Assay 
  The protein content in cell lysates was measured using the Pierce BCA Protein 
Assay Reagent Kit according the manufacturer’s directions. Briefly, cells were lysed 
in the appropriate lysis buffer, and the lysates were cleared by centrifugation at 
11,000 ×g for 10 min at 4°C. The cleared lysates were diluted by a factor of 1:5 using 
lysis buffer in a 96-well microplate in triplicate. Bovine serum albumin (BSA) protein 
concentration standards ranging from 0-1.5 mg/ml were also made in triplicate in the 
same 96-well microplate using the same lysis buffer using a 2 mg/ml stock BSA 
solution (Pierce). The BCA reagents A and B (Pierce) mixed in a 1:5 ratio, and 200 µl 
of this mixture was added to each sample and protein standard well, followed by 
incubation at 37°C for 30 minutes. The absorbance was measured using a BioRad 
spectrophotometer at 562 nm, and the protein concentration of each sample was 
estimated based on the BSA protein concentration standard curve.  
Lactate Dehydrogenase (LDH) Cell Cytotoxicity Assay 
  LDH assays were carried out to normalize luciferase data to adjust for post-
transfection cytotoxicity. Cells were lysed in the appropriate lysis buffer, the lysates 
were cleared by centrifugation at 11,000 ×g for 10 min at 4°C, and 10 µl of the 
cleared lysate was pipetted into a clear same 96-well microplate. A mixture consisting 
of PBS, sodium lactate solution (Sigma), diaphorase solution (Sigma) and 
iodonitrotetrazolium (Sigma) in a 10:10:10:1 ratio was prepared, and 120 µl of this 
mixture was added to each sample well. The absorbance was measured continuously 
at 490 nm over a fixed time period using a BioRad spectrophotometer. 
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CHAPTER 3: Characterizing the endogenous localization of 
Drosophila Evi in S2 cells. 
Introduction 
 Previous studies had found that Wls undergoes endocytosis back to the Golgi 
apparatus to be recycled for multiple rounds of Wnt binding and secretion(Das et al., 
2012b). However, the interaction of Wls with Wnts is mediated by the palmitoleation 
of Wnts by Porcupine, which resides in the endoplasmic reticulum(Proffitt and 
Virshup, 2012). Hence, the conundrum of how palmitoleated Wnts were translocated 
from the ER to the Golgi apparatus for binding to and secretion by Wls remained 
unresolved.  When our laboratory developed an antibody capable of detecting 
endogenous Wls, we decided to investigate the subcellular localization of Wls. Using 
a wide array of in vitro techniques; our laboratory has conclusively demonstrated that 
endogenous Wls resides primarily in the endoplasmic reticulum. Furthermore, 
mutating key conserved residues in the conserved C-terminus KxxQx ER-targeting 
motif impedes the retrograde transport of Wls to the ER and thus diminishes the Wnt 
secretion capacity of Wls. Wls tagged with GFP at the C-terminus was also found to 
mislocalize primarily to the Golgi apparatus via subcellular fractionation(Yu et al., 
2014).   
We decided to investigate whether the retrograde transport of Wls was 
evolutionarily conserved in Drosophila S2 cells. Based on sequence alignments, we 
identified the corresponding C-terminus ER-targeting motif in the Drosophila 
homolog of Wls, Evi. We carried out site-directed mutagenesis on these residues to 
generate untagged Evi as well as Evi mutants deficient in retrograde transport, and 
compared the Wg secretion activity of these mutants with wildtype Evi. We also 
carried out subcellular fractionation to compare the localization of wildtype Evi and 
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Evi tagged with GFP at the C-terminus to determine if tagging Evi at the C-terminus 
also resulted in its mislocalization to the Golgi apparatus. 
 
Materials and Methods 
The DNA and RNA techniques used in this chapter described in Chapter 2 
include: Polymerase chain reactions (PCR), QuikChangeTM site-directed mutagenesis, 
DNA sequencing, PCR clean up, preparation of plasmid DNA and total RNA 
isolation. The cell culture techniques used in this chapter include:  cell culture and 
transient DNA transfection (specific to Drosophila S2 cells). The protein techniques 
used in this chapter include: lysate preparation from cultured cells, analysis of 
protein samples, BCA protein estimation assay and Western transfer and 
immunoblotting. The primers used to generate the mutant Evi constructs can be found 
in Appendix 1.  
Synthesis of dsRNA  
To compare the Wg transportation capabilities of the various Evi mutants, it is 
essential to knock down endogenous Evi in S2 cells. Treating cells with double-
stranded RNA (dsRNA) has been shown to effectively knock down protein expression 
in Drosophila cells(Clemens et al., 2000). To specifically knock down endogenous 
Evi, dsRNA specific to the 5’UTR of Evi is synthesized as per the dsRNA synthesis 
protocol of the Drosophila RNAi Screening Center (http://www.flyrnai.org/DRSC-
PRS.html). Briefly, primers flanked with T7 polymerase sites were used to amplify 
regions of the 5’UTR of endogenous Evi via PCR. After purifying these DNA 
fragments by PCR clean up, dsRNA was synthesized by setting the following 
transcription reaction using reagents from the Ambion T7 MEGAscript® Kit and 
incubating it for 16 hours at 37 °C: 2 µl of 10XT7 Reaction Buffer, 2 µl T7 RNA 
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polymerase, 8 µl dNTP mix (comprised of equal amounts of ATP, GTP, CTP and 
UTP) and 6 µl of purified PCR DNA fragments. Following overnight RNA synthesis, 
1 µl of Turbo DNAse was added to the reaction above to digest away DNA 
fragments. The dsRNA product was purified from the mixture using the total RNA 
isolation method, and 5 µl of the dsRNA eluate was run on a 1% agarose gel to check 
the quality of the dsRNA product. 
dsRNA treatment in S2 cells 
S2 cells were treated with dsRNA as per the specifications of the RNAi 
protocol of the Drosophila RNAi Screening Center (http://www.flyrnai.org/DRSC-
PRS.html). For each well in a 12-well plate, 10 µg of dsRNA suspended in RNAse-
free water was added to cells resuspended in 0.5 ml of serum-free Schneider’s media. 
The dsRNA was incubated with the cells for 30 minutes before adding 1.5 ml 
Schneider’s media supplemented with 10% FBS. To assess the efficacy of dsRNA in 
knocking down endogenous Evi, S2 cells were harvested 3 days following dsRNA 
treatment. For Dual-GLO® Luciferase Assays, cells were treated with dsRNA 24 
hours prior to DNA plasmid transfection. 
 Dual-GLO® Luciferase Assay 
S2 cells transfected with the TCF –responsive luciferase reporter and RNA 
polymerase III-responsive Renilla luciferase reporter plasmids were subjected to the 
Dual-GLO® luciferase assay (Promega) as per the manufacturer’s instructions. 
Transfected cells were washed once with PBS before lysis in 100 µl of Reporter Lysis 
Buffer (Promega) supplemented with complete protease inhibitor cocktail (Roche). 
Cell debris was then removed by centrifugation at 11,000 ×g for 5 min at 4°C. 20 µl 
of the cleared lysate was mixed with 50 µl of luciferase assay reagent (Promega). 
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Firefly luminescence was measured after incubating for 10 minutes at 25°C 
using Tecan Infinite 200 microplate reader (Thermo Scientific) with 1 second 
integration time. Following this measurement, 50 µl of Dual-GLO® Stop & GLO® 
reagent was added to the lysates. Renilla luminescence was measured after incubating 
for 30 minutes at 25°C using Tecan Infinite 200 microplate reader (Thermo 
Scientific) with 1 second integration time so as to normalize firefly luciferase data.  
Subcellular Organelle Fractionation  
Density gradient ultracentrifugation was carried out S2 cells to determine the 
subcellular localization of Evi in S2 cells (Yu et al., 2014). S2 cells grown to 
confluence in 10-cm were re-suspended in 1 ml of homogenization buffer containing 
250 mM sucrose, 10 mM HEPES (pH 7.5), 1 mM KCl, 20 mM NaCl, 1 mM EDTA, 1 
mM sodium orthovanadate, and complete protease inhibitor cocktail (Roche). The cell 
membranes were disrupted by a Dounce homogenizer with a tight-fitting pestle 
(Thermo Scientific) such that more than 90% cells were lysed but with intact nuclei. 
Cell debris consisting of nuclei and intact cells were pelleted by centrifugation at 
3,000 ×g for 10 min at 4oC. Post-nuclear supernatant (PNS) was then overlaid on a 
preformed 0-30% continuous iodixanol gradient (OptiPrep density gradient medium, 
Sigma-Aldrich) and was spun at 50,000 ×g for 16 hours using an SW41Ti swinging 
bucket rotor (Beckman Coulter). The resulting fractions were collected carefully in 
500 µl portions (total 22 fractions) and sample buffer was added directly to each 




Optimizing the synthesis and treatment conditions for dsRNAi of Evi 
 We designed and synthesized dsRNA specific to the 3’UTR of Evi so as to 
specifically knockdown endogenous Evi expression whilst sparing the transfected Evi 
constructs so as to determine the consequence of mutating key Evi residues on Wg 
extracellular secretion. We used the SnapDragon online tool 
(http://www.flyrnai.org/snapdragon) to design suitable dsRNA targeting the 3’UTR of 
Evi, and the primers can be found listed in Appendix 1. Two dsRNAs were 
synthesized and purified (Fig. 3a) and their efficacy in knocking down endogenous 
Evi was tested in S2 cells. Since the antibody used to detect endogenous Evi has not 
been optimized for Western blotting but rather for imaging purposes, its suitability in 
detecting endogenous Evi cannot be completely verified. However, we observed that 
while comparing the efficacy of the two dsRNA for knocking down endogenous Evi, 
the 433 base pair (bp) dsRNA was most effective at depleting endogenous Evi levels 
after 72 hours of incubation at a concentration of 1 µg/ml (Fig. 3b). We proceeded to 
use the 433bp dsRNA for pre-transfection treatment in our subsequent TOPFLASH 
experiments. 
 
Figure 3a: PCR templates for dsRNA synthesis amplified from the 3’UTR 
region of the Evi genomic locus and the subsequent dsRNA synthesized from 
these PCR templates. The protocol was optimized to yield consistent amounts of 
dsRNA for all subsequent experiments.  
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Figure 3b: Testing the efficacy of two dsRNA in knocking down endogenous 
Evi in S2 cells using immunobloting.  The top band in the WCL Evi immunoblots 
(highlighted with a red arrow) corresponds to the total amount of Evi protein 
present in the whole cell lysates. The dsRNA named 433bp was most efficacious at 
knocking down endogenous Evi at 1ug/well in a 24-well format after 72 hours of 
treatment. This treatment protocol was adopted for subsequent TOPFLASH assays. 
 
TOPFLASH Assay results with Evi mutants are ambiguous and irreproducible  
 Based on sequence alignment with human Wls, we identified the key residues 
to mutate in the Drosophila homolog. We generated a variety of Evi mutants to test if 
they phenocopied their mammalian counterparts with respect to Wnt secretion and 
signaling (Table 3c). These mutant Evi constructs were co-transfected into S2 cells 
along with exogenous Wg, Drosophila Frizzled (dFzD) and LEF-1 to compare their 
relative Wg secretion capabilities by carrying out the Dual-GLO® luciferase assay 
described above (Fig.3d).  
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Table 3c: Evi mutants generated using site-directed mutagenesis based on 
sequence alignment with corresponding human Wls mutants. The prediction 
for the Wg signaling phenotype for each Evi mutant is based on observed Wnt 





Figure 3d: TOPFLASH assay of various Evi mutants comparing their 
individual Wg signaling activity over a range of plasmid concentrations (5 ng, 
10 ng and 20 ng of Evi plasmids transfected sequentially per Evi construct). 
Although all Evi mutants exhibit relatively lower Wg signaling compared to 
wildtype Evi, a high degree of variability was observed between replicates. 
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The primary challenge we encountered in these experiments is relatively high 
background Wg signaling that was not effectively diminished upon treating the cells 
with the optimized 433bp dsRNA. Although Evi-GFP, Evi 1-590, Evi-K590A and 
Evi-K590R all demonstrate lower Wg signaling compared to untagged Evi at 5ng 
concentration, this effect did not hold true in a dose-dependent fashion (Fig. 3d). 
Moreover, there was a high degree of variability in the results when we repeated the 
experiment several times. These unfortunate problems could have resulted from an 
incomplete knockdown of endogenous Evi. We decided to try verifying the 
deleterious effect of tagging the C-terminus of Evi on its intracellular localization via 
subcellular organelle fractionation. 
 
Evi antibodies were not suitable for analyzing organelle fractionation results 
 It has been shown that tagging human Wls at the C-terminus causes its 
accumulation in the Golgi apparatus instead of being cycled back to the endoplasmic 
reticulum, as the Wls C-terminus is crucial for intro retrograde transport(Yu et al., 
2014).  We tried to reproduce this finding in S2 cells by carrying out density gradient 
ultracentrifugation on S2 cells and on S2 cells transfected with Evi-GFP. However, 
we encountered many hurdles in interpreting the results of these experiments. The 
primary hurdle was the irregular staining patterns of the Evi antibodies that we used 
to determine the subcellular location of endogenous Evi and Evi-GFP (Fig.3e). 
Furthermore, the antibodies that we used for the detection of Drosophila calnexin 
(endoplasmic reticulum fractions marker) and Drosophila syntaxin (Golgi apparatus 
fractions marker) also gave us highly variable staining patterns (Fig.3e), thereby 
impeding our analysis. Hence, we were unable to reproduce the results obtained with 





Figure 3e: Subcellular organelle fractionation of S2 cells transfected with 
empty vector and Evi-GFP, carried out via density gradient 
ultracentrifugation. Although there is a clear difference in the subcellular 
localization of endogenous Evi and Evi-GFP, the high degree of non-specific 
staining observed with the antibody staining for endogenous Evi, Drosophila 
calnexin and Drosophila syntaxin16 hampered our attempts at interpreting our 
findings.  
 
Summary and Future Directions 
  
The main aim of the experiments in this chapter was to investigate whether the 
results obtained by Dr. Jia Yu regarding the importance of Wls subcellular 
localization in Wnt signaling were reproducible in non-mammalian cell lines. We 
chose the S2 Drosophila cell line for our inquiry because they were amenable to 
transfection assays and have been used before in the study of Wg signaling. One of 
the main problems we encountered was that the S2 cell line we were using tested 
positive for mycoplasma contamination, which has been shown to adversely affect 
TOPFLASH assay results. It is possible that the experiments above would yield more 
consistent and reproducible results if that problem were addressed. We hence decided 
to focus our studies on human Wls as we had the necessary repertoire of tools and 
techniques in our laboratory to do so in an effective and conclusive manner.   
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CHAPTER 4: Determining the biochemical basis of the Wnt-Wls 
interaction 
Introduction 
A lipocalin-like domain near the putative second transmembrane domain closer 
to the N-terminus of Wls is necessary for its association with Wnt1, Wnt3 and Wnt5a 
(Fu et al., 2009). In concurrence with this observation, we have found that the construct 
Wls Δ43-200, albeit exhibiting comparable protein expression level to wildtype Wls, is 
unable to bind and secrete Wnts properly. Our laboratory has shown that the 
palmitoleation of Wnts by Porcupine is essential for the interaction of Wnts with 
Wls(Coombs et al., 2010). The recent high-resolution structure of Wnt8a bound to 
Frizzled indicated the palmitoleate group of Wnt being stabilized by hydrophobic 
residues in the binding pocket of Frizzled(Janda et al., 2012b).  
Recently, the Wnt-binding residues in Porcupine were identified by mutating 
conserved hydrophobic residues in its putative Wnt-interaction region and 
characterizing these mutants via functional assays(Rios-Esteves et al., 2014). 
Therefore, we selected candidate residues in the putative Wnt-binding region based on 
their degree of conservation across various species (Fig. 4a). We extensively 
characterized the subcellular localization, Wnt-binding and secretion capability of these 
Wls point mutants in-vitro using immunofluorescence, immunoprecipitation assays 
with V5-tagged Wnt3a and TOPFLASH Wnt signaling assays respectively. Through 
this comprehensive biochemical analysis, we sought to identify and extensively 





Figure 4a: The putative highly conserved Wnt-binding residues (marked in 
black) in the lipocalin-like hydrophobic pocket (highlighted by a grey box) of Wls 
indicated on a putative structure of Wls generated using Protter 
(http://wlab.ethz.ch/protter/). 
 
Materials and Methods 
 
The DNA techniques used in this chapter described in Chapter 2 include: 
QuikChangeTM site-directed mutagenesis (SDM), DNA sequencing and preparation of 
plasmid DNA. The primers used to generate the Wnt-binding Wls point mutant 
constructs can be found in Appendix 1. The cell culture techniques used in this 
chapter include:  cell culture, transient DNA transfection and siRNA transfection 
(specific for mammalian cell lines). The protein techniques used in this chapter 
include: lysate preparation from cultured cells, analysis of protein samples, BCA 
protein estimation assay, immunoprecipitation and Western transfer and 
immunoblotting. Other experimental techniques used include: immunofluorescence 
microscopy, luciferase assay, mCherry fluorescence assay and lactate dehydrogenase 
(LDH) cell cytotoxicity assay. 
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Results 
All Wls Wnt-binding mutants exhibit comparable subcellular localization to 
wildtype Wls except Wls W148A. 
 Using SDM, we mutated the 10 highly conserved hydrophobic residues in the 
Wnt-binding region of Wls to alanine as highlighted in Figure 4a. We proceeded to 
investigate the subcellular localization of these mutants via immunofluorescence 
staining and confocal microscopy. All mutants were found to localize to the 
endoplasmic reticulum just like wildtype Wls except Wls W148A, as indicated by 
their co-staining patterns with the ER marker, calnexin (Fig.4b). The YJ5 antibody 
did not detect the mutant Wls W148A, thereby suggesting that either mutating this 
residue ablates the Wls epitope of the YJ5 antibody or the mutation destabilizes the 
Wls protein, thereby hampering its steady state cellular expression.  
 
Figure 4b: Comparing the subcellular localization of Wls Wnt-binding 
mutants with wildtype Wls through immunofluorescence staining and confocal 
microscopy. All Wls Wnt-binding mutants exhibit comparable subcellular 
localization to wildtype Wls except Wls W148A. 
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Some Wls Wnt-binding mutants exhibit diminished Wnt signaling. 
Further evidence supporting the destabilizing effect of mutating Wls W148 
was found when TOPFLASH assays were carried out with all the binding mutants. 
Several Wls Wnt-binding mutants exhibit lower Wnt signaling activity compared to 
wildtype Wls (Fig.4c). Wls W148A exhibited almost no Wnt signaling activity, 
demonstrating that transfected Wnt3A was not being secreted to stimulate Wnt 
signaling and thus phenocopying the condition in which endogenous Wls is knocked 
down via siRNA. It is worth noting that not all mutants exhibited diminished Wnt 
signaling, and mutants exhibited lower Wnt signaling in differing magnitudes. The 
preliminary implication is that multiple hydrophobic residues are involved in 
stabilizing the interaction of the putative Wls Wnt-binding region with the 
pamitoleated Wnt3a, and some residues are more critical for this interaction than 
others, namely C50, C71, C162, C179 and L196.  
 
Figure 4c: TOPFLASH assay of various Wls Wnt-binding mutants (2.5 ng, 5 
ng, 10 ng and 20 ng of Wls plasmids transfected sequentially per Wls 
construct) carried out in cells expressing a Wnt-responsive luciferase reporter. 
Some Wls Wnt-binding mutants exhibit diminished Wnt signaling, notably Wls 
C50A, Wls C71A, Wls C162A, Wls C179A and Wls L196A.  
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W106 is important for stabilizing the interaction between Wls and Wnt3a. 
To assess the in vitro binding capacity of the Wls Wnt-binding mutants, we 
carried out immunoprecipitation experiments with V5-tagged Wnt3a, followed by 
comparing and quantifying the amount of wildtype and various Wls mutants bound to 
Wnt3a (Fig 4d). We normalized the amount of Wls bound to V5-tagged Wnt3a to the 
total Wls protein expression to control for differences of protein expression between 
the various Wls mutants.  
Upon examining the protein expression of all the Wls Wnt-binding mutants, 
we could immediately confirm our hypothesis regarding the destabilizing effect of 
mutating the residue W148 on the overall protein stability of Wls, as evidenced by its 
compromised protein expression as well marked absence when immunoprecipitating 
Wnt3a (Fig.4d).  Surprisingly, we found some Wls mutants were bound more strongly 
to Wnt3a (Fig. 4e). However, the mutants demonstrating equivalent or lower binding 
affinity to Wnt3a, particularly Wls W106A, intrigued us. These results led us to 
conclude that the residue W106 plays an important role in stabilizing the interaction 
between the pamitoleated of Wnt3a and the putative Wnt-binding region of Wls.  
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Figure 4d: Immunoprecipitation assay comparing the Wnt3a binding affinity 
between wildtype Wls and the various Wnt-binding Wls mutants. The results of three 






Figure 4e: Quantification of immunoprecipitation assays between wildtype 
Wls and the various Wnt-binding Wls mutants (n=3). The binding affinity of 
Wls W106A is lower compared to wildtype Wls (p<0.05), thereby suggesting that it 
is crucial for stabilizing the Wnt-Wls interaction.  
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Summary and Future Directions 
 
Table 4f summarizes the key findings for the Wls Wnt-binding mutants with 
respect to their binding affinity to and secretion capacity of Wnt3a. We have 
specifically omitted Wls W148 from this analysis, as mutating this residue adversely 
impacts the intracellular protein levels of Wls. The residues C50, C71 and L196 all 
demonstrate comparable affinity to Wnt3a when compared to wildtype Wls, and may 
be acting in a concerted manner along with the key residue W106 to stabilize the 
interaction between Wls and the hydrophobic Wnt3a palmitoyl tail. It would be 
interesting to investigate the effect of mutating all these four candidate residues 
simultaneously on Wnt binding and secretion. 
Table 4f: Summary of the Wnt signaling activity and Wnt3a binding affinity of 
the putative Wnt-binding residues of Wls with respect to wildtype Wls. The 
residues C50, C71, W106 and L196 may be acting in a concerted manner to 
stabilize the Wnt-Wls interaction. 
 
Unlike the TOPFLASH assays where endogenous Wls is knocked down, the 
presence of endogenous Wls is a major limitation in effectively interpreting the 
immunoprecipitation results. This preliminary foray into the Wnt-binding 
mechanisms of Wls would hence benefit greatly from being mechanistically validated 
in a Wls knockout cell line. Future directions would include identifying the Wnt-
binding motif in Wls and generating Wls ‘knock-in’ cell lines containing the validated 
Wnt-binding mutations and charactering the phenotypic consequences. From a 
therapeutic standpoint, these residues can serve as preliminary target for developing 
specific small molecule/ peptide inhibitors of the Wnt-Wls interaction, thereby 
presenting an alternative means of targeting Wnt-driven pathologies.  
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CHAPTER 5: Investigating the role of intracellular pH changes in 
the dissociation of Wnts from Wls 
Introduction 
Several transmembrane proteins are known to change their conformation in 
response to intracellular pH changes (Ludwig et al., 2003). The primary mechanism 
behind this ‘pH sensing’ is the protonation and deprotonation of the imidazole side 
chains (pKa=6.0) of histidine residues. The histidine imidazole side chain is therefore 
able to exhibit dual conformation states based on its protonation status in the cellular 
secretory pathway (Borza and Morgan, 1998; Vishwanatha et al., 2014). This pH-
induced conformational change has been implicated in the release of cargo proteins 
from their transmembrane transporter protein during intracellular trafficking 
(Appenzeller-Herzog et al., 2004).  
 
To investigate whether Wls possesses ‘pH sensing’ capabilities, we mutated 17 
histidine residues in Wls that may be inducing conformational changes in response to 
pH changes, thereby facilitating Wnt dissociation (indicated in Figure 5a). We mutated 
these histidine residues to glutamine, which results in pH-insensitivity without 
compromising on the overall contribution of the mutated residue to protein secondary 
structure(Appenzeller-Herzog et al., 2004). We first mutated the histidine residues in 
the luminal Wnt-binding domain of Wls, and then proceeded to mutate all histidine 
residues in Wls, including those in the putative cytosolic loops of Wls (Fig.5a). Upon 
confirming that these Wls mutants exhibit comparable protein expression and cellular 
localization to wildtype Wls, we then proceeded to compare these Wls mutants based 
on their affinity for Wnt ligands and their ability to secrete Wnts through 
immunoprecipitation assays and TOPFLASH assays respectively. 
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Figure 5a: The 17 histidine residues (marked in black) in Wls that were 
mutated to glutamine indicated on a putative structure of Wls generated using 
Protter (http://wlab.ethz.ch/protter/). Nine of these residues can be found in the 
lipocalin-like hydrophobic Wnt-binding pocket (highlighted by a grey box), and the 
remaining 8 residues are present mainly in the putative cytoplasmic domains of 
Wls.  
 
Variants of Green Fluorescent Protein (GFP), named pHluorins, are sensitive to 
pH changes and have been used to visualize the vesicular trafficking of proteins. 
Specifically pHluorin2 possesses the required ratiometric pH-sensitivity to small 
changes in pH whilst exhibiting increased fluorescence compared to other pH-sensitive 
GFP variants (Mahon, 2011). Using the laboratory’s repository of active V5-tagged 
Wnts (MacDonald et al., 2014; Najdi et al., 2012), we inserted pHluorin2 into the C-
terminus candidate Wnts, namely Wnt1, Wnt3a, Wnt5a and Wnt7a, as well as cloned a 
Wls-pHluorin2 fusion construct. We tested the protein expression, subcellular 
localization and biological activity of all these constructs to determine their suitability 
for future live-cell imaging experiments. 
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 Our laboratory has previously shown that various acidification inhibitors such 
as bafilomycin and monensin with distinct mechanisms are able to effectively block 
Wnt3a secretion and cause Wnt-Wls complexes to accumulate on the plasma membrane 
(Coombs et al., 2010).We hypothesized that intracellular pH changes may be the 
physiological cue in the exocytotic route for the intracellular dissociation of all 
mammalian Wnts bound to Wls. To test our hypothesis, we investigated the 
intracellular accumulation and extracellular secretion patterns of all mammalian Wnts 
from our Wnt library in a variety of cell lines upon bafilomycin treatment.  
 
Materials and Methods 
 
The DNA techniques used in this chapter described in Chapter 2 include: 
QuikChangeTM site-directed mutagenesis, DNA sequencing and preparation of 
plasmid DNA. The primers used to generate the Wnt-binding Wls point mutant 
constructs can be found in Appendix 1. For cloning multiple Wnts tagged with 
pHluorin2 as well as 3XFLAG Wls internally tagged with pHluorin2, the following 
DNA techniques were used:  polymerase chain reactions (PCR), restriction 
endonuclease-based cloning, gel extraction and PCR clean up, ligation and 
transformation, DNA sequencing and preparation of plasmid DNA. The primers used 
for cloning the above-mentioned constructs can be found in Appendix 1.  
The cell culture techniques used in this chapter include: cell culture, 
transient DNA transfection and siRNA transfection (specific for mammalian cell 
lines). The protein techniques used in this chapter include: lysate preparation from 
cultured cells, analysis of protein samples, BCA protein estimation assay, 
immunoprecipitation and Western transfer and immunoblotting. Other experimental 
techniques used include: immunofluorescence microscopy, luciferase assay, mCherry 
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fluorescence assay and lactate dehydrogenase (LDH) cell cytotoxicity assay. 
Wavelength Excitation Assay 
The wavelength excitation assay is carried out to measure the intracellular 
amounts of pHluorin2-tagged Wnts. HeLa cells transfected with pHluorin2-tagged 
Wnts were washed once with PBS and resuspended in phenol-free colorless DMEM 
media supplemented with 10% FBS, sodium pyruvate and penicillin/streptomycin. 
Excitation scans were performed on the cells using wavelengths ranging from 350 nm 
to 490 nm, and resultant emission was measured at 5nm intervals using Tecan Infinite 
200 microplate reader (Thermo Scientific). 
 
Results 
Most Wls histidine mutants are phenotypically comparable to wildtype Wls 
 We investigated the subcellular localization of all the Wls histidine mutants 
via immunofluorescence coupled with confocal microscopy. All mutants were found 
to localize to the endoplasmic reticulum just like wildtype Wls as indicated by their 
co-staining patterns with the ER marker, calnexin (Fig.5b, 5c). We further compared 
the Wnt3a-binding capacities of all the histidine mutants with wildtype Wls through 
immunoprecipitation binding affinity assays (Fig. 5d, Fig.5e). Upon testing the Wnt 
secretion capacity of the various mutants by TOPFLASH assays, we identified the 
histidine mutants that demonstrated diminished Wnt signaling as being deficient in 




Figure 5b: Comparing the subcellular localization of conserved Wls histidine 
mutants in the putative Wnt-binding region with wildtype Wls through 
immunofluorescence staining and confocal microscopy. All histidine mutants 
exhibit comparable subcellular localization to wildtype Wls. 
 
 
Figure 5c: Comparing the subcellular localization of cytoplasmic Wls histidine 
mutants with wildtype Wls through immunofluorescence staining and confocal 





Figure 5d: Immunoprecipitation assay comparing the Wnt3a binding affinity 
between wildtype Wls and the conserved Wls histidine mutants in the putative 
Wnt-binding region.  
 
 
Figure 5e: Immunoprecipitation assay comparing the Wnt3a binding affinity 
between wildtype Wls and cytoplasmic Wls histidine mutants.  
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Figure 5f: TOPFLASH assay of the conserved Wls histidine mutants in the 
putative Wnt-binding region (2.5ng, 5ng, 10ng and 20ng of Wls plasmids 
transfected sequentially per Wls construct) carried out in cells expressing a Wnt-
responsive luciferase reporter.  
 
 
Figure 5g: TOPFLASH assay of cytoplasmic Wls histidine mutants (2.5ng, 5ng, 
10ng and 20ng of Wls plasmids transfected sequentially per Wls construct) 
carried out in cells expressing a Wnt-responsive luciferase reporter. 
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Wls H192Q and Wls H496Q bind more strongly to Wnt3a 
Based on our hypothesis and the results above, we repeated the 
immunoprecipitation assays and TOPFLASH assays for the mutants exhibiting 
diminished Wnt secretion. We normalized the amount of Wls bound to V5-tagged 
Wnt3a to the total Wls protein expression to control for differences of protein 
expression between the various Wls mutants. Although seven histidine mutants 
showed significant reduction in Wnt secretion (Fig. 5h), only Wls H192Q and Wls 
H496Q exhibit higher binding affinity to V5-tagged Wnt3a (Fig. 5i, Fig. 5j). Taken 
together, we can further hypothesize that mutating these two highly conserved 
histidine residues compromises the pH-sensing capability of Wls, thereby impeding 
release of bound Wnt3a. Based on the putative structure of Wls, H192 is situated in 
the proposed luminal Wnt-binding region of Wls, whereas H496 is located in the 4th 
intracellular loop. Since the proposed Wls luminal loops are exposed to vesicular 
acidification during exocytosis, it is likely that H192 is involved in the pH-sensing 
mechanism of Wnt-Wls dissociation, albeit the possibility of an allosteric 
conformational change initiated by H496 cannot be completely ruled out.  
 
Figure 5h: TOPFLASH assay of seven Wls histidine mutants (2.5ng, 5ng, 10ng 
and 20ng of Wls plasmids transfected sequentially per Wls construct) that 
exhibit diminished Wnt secretion compared to wildtype Wls; carried out in 




Figure 5i: Immunoprecipitation assay comparing the Wnt3a binding affinity 
between wildtype Wls and the selected 7 Wls histidine mutants. The results of 
three replicates of this assay have been quantified in Figure 5j. 
 
Figure 5j: Quantification of immunoprecipitation assays between wildtype Wls 
and the selected 7 Wls histidine mutants (n=3). The binding affinity of Wls 
H192Q and Wls H496Q is higher compared to wildtype Wls (p<0.05), thereby 
suggesting that these Wls residues may be facilitating the pH-sensitivity of the 
dissociation of Wnt from Wls.  
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Wnt secretion patterns of different Wnts differ in different cell types 
 It has been previously reported that inhibiting vesicular acidification using 
acidification inhibitors such as bafilomycin and monensin results in intracellular 
Wnt3a accumulation and inhibits extracellular secretion of Wnt3a(Coombs et al., 
2010). We thus hypothesized that this pattern will hold true for all Wnts, and 
examined the intracellular accumulation and extracellular secretion patterns of five 
candidate Wnts upon bafilomycin treatment. To our surprise, we found that although 
the phenomenon of intracellular accumulation was consistent for increasing 
concentrations of all four Wnts upon bafilomycin treatment, the extracellular 
secretion of Wnt1 and Wnt9a increased upon bafilomycin secretion (Fig. 5k). These 
baffling results prompted us to test the intracellular accumulation and extracellular 
secretion patterns of all 19 human Wnts upon bafilomycin treatment. We found that 
although all Wnts exhibited intracellular accumulation upon inhibiting vesicular 
acidification, they exhibited considerable variation in extracellular secretion patterns 
(Fig.5l). The extracellular secretion patterns of all Wnts are summarized in Table 5m. 
 This unexpected result prompted us to investigate the effect of bafilomycin 
treatment on Wnt accumulation/secretion patterns in different cell types. We found 
that the marked intracellular Wnt accumulation and extracellular secretion patterns 
observed in HEK293 cells in all previous experiments were not observed in HeLa and 
HT1080 cells lines. We were unable to detect extracellular secretion of Wnts in both 
HT1080 and HeLa cells despite both exhibiting robust Wnt signaling in TOPFLASH 
assays (Fig.5n, Fig. 5o). Furthermore, there was no marked intracellular accumulation 
of candidate Wnts upon bafilomycin treatment in both HeLa and HT1080 cells 
(Fig.5n, Fig. 5o), in stark contrast to consistent intracellular accumulation patterns in 




Figure 5k: Immunoblot analysis of Wnt intracellular accumulation and 
extracellular secretion patterns of five candidate V5-tagged Wnts (Wnt1, 
Wnt3a, Wnt5a, Wnt7a and Wnt9a) in HEK293 cells upon 50nM bafilomycin 
treatment. Although all Wnts exhibit intracellular accumulation; Wnt3a, Wnt5a 
and Wnt7a exhibit decreased extracellular secretion whereas Wnt1 and Wnt9a 









Figure 5l: Immunoblot analysis of Wnt intracellular accumulation and 
extracellular secretion patterns of all 19 mammalian V5-tagged in HEK293 
cells upon 50nM bafilomycin treatment. All 19 Wnts exhibit increased 
intracellular accumulation upon bafilomycin treatment. The variations in 
extracellular secretion levels of various Wnts upon bafilomycin treatment are 
summarized in Table 5m.  
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Table 5m: Extracellular secretion patterns of all 19 mammalian Wnts upon 




Figure 5n: Immunoblot analysis of Wnt intracellular accumulation and 
extracellular secretion patterns of five candidate V5-tagged Wnt1 and Wnt3a 
in HT1080 cells upon 50nM bafilomycin treatment. No consistent pattern of Wnt 




Figure 5o: Immunoblot analysis of Wnt intracellular accumulation and 
extracellular secretion patterns of five candidate V5-tagged Wnt1 and Wnt3a 
in HeLa cells upon 50nM bafilomycin treatment. No consistent pattern of Wnt 




pHluorin2-tagged Wnts exhibit intracellular accumulation upon bafilomycin 
treatment 
 To further characterize the intracellular accumulation patterns of Wnts in 
response to vesicular acidification inhibition, we cloned pHluorin2 into the C-
terminus of four candidate Wnts. The resultant Wnt- pHluorin2 fusion proteins 
exhibit proper protein expression and extracellular secretion (Fig. 5p), are able to 
initiate Wnt signaling (Fig. 5q) and are fluorescent (Fig. 5r). Wavelength scans of 
HeLa cells transfected with these Wnt-pHluorin2 constructs indicate intracellular 
accumulation upon bafilomycin treatment, thereby mimicking the biological effect of 
treatment with the Porcupine inhibitor C59 (Fig. 5s).  
 
Figure 5p: Immunoblot analysis of protein expression and extracellular 
secretion of candidate V5-tagged Wnts and the corresponding pHluorin2 
(pH2)-tagged Wnts. The pHluorin2-tagged Wnts exhibit greater intensity upon 
staining with anti-V5 antibody due to increased exposure of the V5 epitope to 




Figure 5q: TOPFLASH assay of V5-tagged Wnt1 and pHluorin2-tagged (100 
ng, 200 ng and 400 ng of Wnt plasmids transfected sequentially per Wnt 
construct) carried out in cells expressing a Wnt-responsive luciferase reporter. 
Both constructs exhibit comparable Wnt signaling activity, indicating that 
pHluorin2 tagging does not disrupt biological activity 
 
 
Figure 5r:  All pHluorin2-tagged Wnts fluoresce.  
 
 
Figure 5s: Wavelength exaction scans of HeLa cells transfected with 
pHluorin2-tagged Wnt1, Wnt5a and Wnt7a and treated with DMSO, 50 nM 
bafilomycin and 10nM Porcupine inhibitor, C59. Both bafilomycin treatment 
and C59 treatment results in the intracellular accumulation of Wnts, albeit to 
different degrees in the various pHluorin2-tagged Wnts. 
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Wls-pHluorin2 fusion protein is viable for live cell imaging 
We cloned pHluorin2 into an amenable extracellular loop of Wls (Beckett et 
al., 2013), so as to directly monitor its anterograde and retrograde transport dynamics 
and the accompanying pH changes via live cell imaging. The Wls-pHluorin2 fusion 
protein is expressed (Fig.5t), exhibits proper subcellular localization (Fig.5u) and is 
marginally biologically active (Fig. 5v), thereby rendering it suitable for live cell 
imaging experiments. 
 
(clockwise) Figure 5t:  Immunoblot analysis of protein expression Wls-
pHluorin2 fusion protein, indicating marginal protein expression.  
Figure 5u: Comparing the subcellular localization of Wls-pHluorin2 with 
wildtype Wls through immunofluorescence staining and confocal microscopy. 
Wls-pHluorin2 exhibits similar subcellular localization.  
Figure 5v: TOPFLASH assay of wildtype Wls and Wls-pHluorin2 (5 ng, 10 ng 
and 20 ng of Wls plasmids transfected sequentially per Wls construct) carried 
out in cells expressing a Wnt-responsive luciferase reporter. Wls-pHluorin2 is 




Summary and Future Directions 
 We sought to understand the biochemical dynamics governing Wnt 
dissociation from Wls and Wnt extracellular secretion in the context of exocytotic 
vesicular acidification. Our preliminary findings confirm our hypothesis that Wls may 
indeed be acting as a pH sensor through conserved histidine residues inducing 
conformational changes that facilitate the dissociation of Wnts prior to exocytosis 
(Fig.5j). Although the exact mechanism is yet to be elucidated, we believe that this 
finding demonstrates a new means of regulation in the Wnt secretion pathway.  
 We were very surprised to discover the differential patterns of Wnt 
extracellular secretion when comparing different Wnts in HEK293 cells (Table 5m). 
Recently, genomic transcriptional profiling studies have concluded that HEK293 cells 
are from an adrenal lineage(Lin et al., 2014), thereby bestowing them with phenotypic 
properties of secretory cells. This finding may explain the differential extracellular 
secretion patterns that were not observed in HeLa cells (epithelial in origin) or 
HT1080 cells (mesenchymal in origin) (Fig.5n, 5o), despite both exhibiting Wnt 
signaling. We were able to detect intracellular accumulation of Wnt-pHluorin2 
proteins upon bafilomcyin treatment via wavelength scans in HeLa cells, probably 
due to the greater sensitivity of this method compared to immunoblot analysis.  
Subsequent studies would include using both the Wls-pHluorin2 and Wnt-
pHluorin2 fusion proteins for high-resolution live-cell imaging to visualize the 
intracellular trafficking and dissociation of Wnts from Wls in response to vesicular 
acidification. The ratiometric shift in the pHluorin2 emission spectra allows us to 
monitor the pH changes inherent in Wnt intracellular trafficking in a reliable 
quantitative fashion. These studies will provide new insights into the chemo-dynamics 
of the Wnt secretion pathway. 
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CHAPTER 6: Characterizing novel interacting partners of Wls 
relevant to the Wnt secretion pathway 
Introduction 
Conventional methods of identifying novel interacting partners of a protein-of-
interest have included immunoprecipitation of the over-expressed candidate protein 
followed by SDS-PAGE gel electrophoresis and mass spectrometric analysis of unique 
protein bands identified through Coomassie and/or silver gel staining. However, it is 
difficult to capture weak and transient interactions occurring in the cellular environment 
that may be disrupted during this entire process. Therefore, Roux et al developed a 
promiscuous biotin ligase (BirA*) from Escherichia coli that can be fused to a cytosolic 
protein-of-interest. This fusion protein catalyzes the biotinylation of proximal 
interacting proteins upon the addition of biotin. The biotinylated proteins can then be 
identified via conventional mass spectrometry, thereby reducing the false positive ‘hits’ 
whilst detecting transient biotinylated interacting partners (Roux et al., 2012).   
We tried to generate a Wls-BirA fusion protein, but were unsuccessful. 
However, using this innovative approach for protein interactome studies, the Gingras 
laboratory identified several cytosolic proteins that interact with Wls (Dr.Gingras, 
personal communication). We proceeded to validate these interactions as being Wls-
specific by knocking down these candidate interacting proteins using siRNA and 
determining whether they are involved in the Wnt secretion pathway. We also cloned 
an internally tagged 3XFLAG Wls construct and characterized its biological 
properties to use for traditional immunoprecipitation experiments and mass 




Materials and Methods 
 
The cell culture techniques used in this chapter include:  cell culture, 
transient DNA transfection and siRNA transfection (specific for mammalian cell 
lines). The protein techniques used in this chapter include: lysate preparation from 
cultured cells, analysis of protein samples, BCA protein estimation assay, 
immunoprecipitation and Western transfer and immunoblotting. To verify the 
specificity of the siRNA pools used to knockdown potential Wls interaction partners, 
the following RNA techniques were used: total RNA isolation, reverse transcription 
of total RNA and quantitative real-time PCR. A list of qPCR primers used can be 
found in Appendix 1.  
For cloning the internally-tagged 3XFLAG Wls contruct, the following 
techniques described in Chapter 2 were used: polymerase chain reactions (PCR), 
restriction endonuclease-based cloning, gel extraction and PCR clean up, ligation and 
transformation, DNA sequencing and preparation of plasmid DNA. The primers used 
for cloning the internally tagged 3XFLAG Wls construct can be found in Appendix 1. 
Other experimental techniques used include: immunofluorescence microscopy, 
luciferase assay, gaussia luciferase secretion assay, mCherry fluorescence assay and 
lactate dehydrogenase (LDH) cell cytotoxicity assay.  
FLAG Peptide Competitive Binding Elution 
 Lysates from cells transfected with FLAG empty vector and FLAG-tagged 
Wls were subjected to immunoprecipitation using FLAG M2-conjugated beads 
(Sigma).  After the pelleted immunoprecipitates were washed thrice with lysis buffer, 
they were incubated with 45ul of 150ug/ml 3XFLAG peptide solution (3XFLAG 
peptide reconstituted in TBS buffer) (Sigma) for 30 minutes at room temperature with 
occasional agitation. The mixture was then spun for 5 minutes at 100 ×g , and the 
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supernatant (containing the eluted FLAG-Tagged protein complexes) was added to 2× 
sample buffer, boiled at 95°C for 5 min and then subjected to SDS-PAGE analysis. 
Silver Staining 
 To visualize novel protein interacting partners of FLAG-tagged Wls, silver 
staining was carried out on gels after SDS-PAGE analysis. The polyacrylamide gels 
were incubated twice for 15 minute intervals in 250 ml of 50% HPLC-grade methanol 
(Fisher), followed by two incubations of 5 minute intervals in 250 ml of 5% methanol 
and a 15-minute incubation in 250ml picopure water containing 6mM dithiothreitol 
(Gold Biotech). After rinsing briefly twice with picopure water, the gel was incubated 
in silver nitrate (Sigma) solution for 15 minutes. After rinsing briefly twice with 
picopure water, the gel was incubated with developing solution comprising of sodium 
carbonate (Sigma) and formaldehyde (Sigma) until dark-colored bands of desired 
intensity appeared, whereupon which excess powdered citric acid was added to the 
developing solution to stop the reaction. The gel is then repeatedly rinsed and 
incubated in picopure water to minimize non-specific staining.  The gel was scanned 
using an Epson Perfection V700 scanner.  
Coomassie Staining 
To visualize novel protein interacting partners of FLAG-tagged Wls and 
excise the relevant bands for mass spectrometric analysis, Coomassie staining was 
carried out on gels after SDS-PAGE analysis. The polyacrylamide gels were 
incubated in a solution comprising of 0.1% Coomassie® Brilliant Blue G250 (Sigma), 
10% acetic acid (Sigma), 50% methanol (Sigma) and 40% water for one hour. The gel 
was then destained in a solution comprising of 10% acetic acid (Sigma), 50% 
methanol (Sigma) and 40% water for two hours with frequent solvent changes to 
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Wls-BirA fusion protein is not viable  
Since Wls undergoes both anterograde and retrograde transport in the cell, its 
interactions with other intracellular proteins might be transient. As tagging Wls at the 
N-terminus or C-terminus adversely impacts its intracellular trafficking, we cloned 
BirA into an amenable extracellular loop of Wls (Beckett et al., 2013), so as to 
identify these transient interacting partners via biotinylation. To our disappointment, 
the Wls-BirA fusion protein is poorly expressed (Fig.6a, 6b) and is not biologically 
active (Fig. 6c), thereby rendering it unsuitable for further use.  
 
(clockwise) Figure 6a:  Immunoblot analysis of protein expression Wls-BirA 
fusion protein, indicating poor protein expression.  
Figure 6b: Comparing the subcellular localization of Wls-BirA with wildtype 
Wls through immunofluorescence staining and confocal microscopy. Wls-BirA 
is hardly detectable.  
Figure 6c: TOPFLASH assay of wildtype Wls and Wls-BirA (5 ng, 10 ng and 
20 ng of Wls plasmids transfected sequentially per Wls construct) carried out 
in cells expressing a Wnt-responsive luciferase reporter.  Wls-BirA is 
biologically inactive with respect to Wnt secretion and signaling. 
 67 
ATP2A1 inhibits downstream Wnt signaling, not Wnt secretion 
 We obtained data from our collaborator Dr. Gingras that identified BirA-
tagged cytosolic proteins that had biotinylated Wls (Table 6d). We proceeded to 
validate the biological consequence of these potential Wls interacting proteins in the 
context of Wnt signaling and secretion. Upon knocking down these candidate proteins 
with pooled siRNA, we observed a significant, selective and reproducible 
downregulation of Wnt signaling with ATP2A1 siRNA (Fig.6e).  Upon checking the 
specificity of the siRNA pools in knocking down our candidate interacting proteins, 
we found that our siRNA pools were achieving significant and specific knockdown 
efficiency (Fig. 6f). 
Table 6d: Potential cytosolic interacting partners of Wls and their corresponding 
role in Wnt signaling. 
 




Intracellular SERCA Ca2+-ATPase pump. 







Located in calveolae (lipid rafts), interacts 
with several GPCRs. Acts as a key scaffold 
for integrin subunits(Kobrinsky, 2015). 
Yes, stimulates Wnt 
signaling through its 
interaction with 




Found in ER, Part of ERAD complex, 
promotes Erk phosphorylation(Lemberg, 
2013). 
Indirectly.CAV1 is a co-
factor promoting the 
ERAD activity of 




Found in early endosomes, associated with 
metastasis in breast, lung & ovarian 







Figure 6e: TOPFLASH assay of siRNA knockdown of potential Wls interaction 
partners (transfected with 50nM siRNA, 50ng Wnt3a/well) carried out in cells 
expressing a Wnt-responsive luciferase reporter. There is a significant, 




Figure 6f: qPCR assay of siRNA knockdown of potential Wls interaction 
partners (50nM siRNA) in HEK293 cells. Relative mRNA expression is 
normalized to housekeeping gene GAPDH. The targeting siRNA pools are specific 




We decided to investigate the non-specific effects of knocking down these 
proteins on the luciferase reporter and extracellular secretion so as to rule out possible 
experimental artifacts.  Cells were transfected with a construct bearing a β-tubulin 
responsive luciferase reporter following siRNA knockdown of the candidate proteins, 
and luciferase activity was measured. Crucially, no significant variation was observed 
between knocking down Wls and ATP2A1 (Fig. 6g). As for extracellular protein 
secretion, knocking down ATP2A1 resulted in a significant increase in gaussia 
luciferase secretion (Fig. 6h). Based on these results, we hypothesized that ATP2A1 
might be interacting with Wls in a manner to specifically down regulate Wnt secretion 
and consequently, Wnt signaling.  
 
Figure 6g: TOPFLASH assay of siRNA knockdown of potential Wls 
interaction partners (transfected with 50nM siRNA, 100ng untagged 
Wnt1/well and b-actin luciferase reporter) carried out in HT1080 cells. 
Knocking down ATP2A1 does not affect luciferase reporter activity in a non-
specific manner. 
 
Figure 6h: TOPFLASH assay of siRNA knockdown of potential Wls 
interaction partners (transfected with 50nM siRNA, 100ng untagged 
Wnt1/well and Gaussia luciferase) carried out in HT1080 cells. Knocking down 
ATP2A1 results in a significant increase in Gaussia luciferase secretion. 
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If our hypothesis was indeed true, then we would expect to see no change in 
Wnt signaling activity in conditions where ATP2A1 is knocked down and Wnt 
stimulation occurs in an extraneously fashion (i.e. cells are treated with Wnt3a-
conditioned media instead of exogenous Wnt3a transfection). However, we saw a 
consistent down regulation of Wnt signaling upon knocking down ATP2A1 followed 
by Wnt stimulation via conditioned media (Fig. 6i). This observation is in stark 
contrast to knocking down Wls, which does not result in a down-regulation of Wnt 
signaling upon conditioned media treatment. This result suggests that ATP2A1 is 
most probably inhibiting downstream Wnt signaling, and is not specifically involved 
in Wnt secretion. Hence, we decided to focus on isolating potential protein interactors 
via Wls immunoprecipitation instead of further characterizing these likely false 
positive candidates.  
 
Figure 6i: TOPFLASH assay of siRNA knockdown of potential Wls interaction 
partners (transfected with 50nM siRNA, treated with Wnt3a conditioned 
media) carried out in cells expressing a Wnt-responsive luciferase reporter. 
There is a significant, reproducible down regulation of Wnt signaling observed 
upon knocking down ATP2A1, thereby implying that ATP2A1 inhibits downstream 
Wnt signaling and not Wnt secretion via Wls interaction.  
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3XFLAG Wls is biologically active and amenable to immunoprecipitation 
 Although we have generated antibodies in our laboratory that are capable of 
detecting endogenous Wls, they are not suitable for immunoprecipitation. Tagging 
proteins with the FLAG epitope results in cleaner immunoprecipitation results. We 
tested the viability of a human Wls construct tagged with a single FLAG epitope at 
the N-terminus. Unfortunately, although this construct demonstrated high protein 
expression, it was found to mislocalize compared to untagged Wls and was 
consequently deficient in Wnt secretion. Hence, we cloned a 3XFLAG tag into an 
amenable extracellular loop of Wls (Beckett et al., 2013). We then compared the 
protein expression by Western blotting, subcellular localization by 
immunofluorescence confocal microscopy and Wnt secretion activity by TOPFLASH 
assays. The internally tagged 3XFLAG Wls construct is biologically comparable to 
untagged Wls with respect to protein expression (Fig.6j), subcellular localization 
(Fig.6k) and Wnt secretion (Fig.6l).  
We then proceeded to test the suitability of this construct for 
immunoprecipitation procedures. The internally tagged Wls protein was successfully 
eluted from FLAG-conjugated beads by FLAG peptide elution, and was detected by 
immunoblotting as well as Coomassie and silver staining (Fig. 6m). Therefore, this 
Wls construct is suitable for immunoprecipitation followed by mass spectrometric 






(clockwise) Figure 6j:  Immunoblot analysis of protein expression of 3XFLAG 
Wls, indicating good protein expression.  
Figure 6k: Comparing the subcellular localization of 3XFLAG Wls with 
wildytpe Wls through immunofluorescence staining and confocal microscopy. 
3XFLAG Wls exhibits similar subcellular localization.  
Figure 6l: TOPFLASH assay of wildtype Wls and 3XFLAG Wls (5ng, 10ng 
and 20ng of Wls plasmids transfected sequentially per Wls construct) carried 
out in cells expressing a Wnt-responsive luciferase reporter. 3XFLAG Wls is 




Figure 6m: Immunoblot analysis, silver staining and Coomassie staining to 
detect immunoprecipitation of 3XFLAG Wls. The internally tagged 3XFLAG 
Wls construct is amenable to immunoprecipitation and can be detected by 
immunoblotting, silver staining and Coomassie staining (demarcated by a red box) 
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Summary and Future Directions 
 
 The identification and characterization of interaction partners of a 
transmembrane, actively circulating protein such as Wls is challenging in two ways: 
interactions with other proteins may be transient due to constant intracellular 
trafficking and transmembrane proteins are usually not amenable to being tagged 
internally. We sought to overcome these challenges by employing several alternative 
approaches. The candidate cytosolic interactors of Wls are probably false positive, 
and are not relevant to the Wnt secretion pathway. Although the Wls-BirA fusion 
protein was not viable, the internally tagged 3XFLAG Wls protein is biologically 
similar to untagged Wls and is amenable to immunoprecipitation.  
 
The current over-expression levels of Wls are probably insufficient to 
successfully pull down sufficient quantities of interacting proteins for mass 
spectrometric detection and identification. To address this issue, we have cloned the 
tagged Wls construct into an adenoviral vector, and are currently optimizing the 
expression and purification of Wls using this approach in multiple mammalian cell 
lines (HEK293, HeLa and HT1080 cells) to identify potential interacting partners. 
The Wls knockout cell line that we are currently generating (please refer to Chapter 7) 
would serve as an ideal negative control for these experiments, as we can then 
eliminate false positive interacting partners with greater ease and confidence from 
further characterization. Once identified, we can verify and characterize the role of 
these interacting proteins in the Wnt secretion pathway via co-immunoprecipitation 
experiments and TOPFLASH assays respectively.  
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CHAPTER 7: Engineering a Wls knockout cell line using 
CRISPR/Cas9 genome engineering technology 
Introduction 
The deletion of the O-acyltransferase Porcupine is well tolerated in the 
fibrosarcoma HT1080 cell line with respect to cell viability and proliferation (Proffitt 
and Virshup, 2012). Furthermore, HT1080 cells are pseudo-diploid and responsive to 
Wnt stimulation in TOPFLASH assays, and exhibit relatively high levels of 
endogenous Wls expression (Yu et al., 2014). Hence, we are attempting to generate 
Wls homozygous knockout HT1080 cells using the revolutionary and highly efficient 
CRISPR/Cas9 genome editing system (Cong et al., 2013; Mali et al., 2013b). 
Recently, improved lentiviral CRISPR/Cas9 vectors have been developed which 
significantly increase the probability of genomic disruption of the desired locus due to 
improved, constitutive expression of the targeting guides as well as Cas9 
enzyme(Sanjana et al., 2014). Furthermore, we are using a high-throughput screening 
capillary electrophoresis method developed by Dr. Li Shang’s laboratory in Duke-
NUS Graduate Medical School to expedite the isolation of single-cell populations 
bearing genomic disruptions in the Wls locus. The resultant homozygous Wls 
knockout HT1080 cell line will be used for rigorously validating the Wnt binding and 
secretion phenotypes observed in the various Wls mutants we have generated in our 
laboratory.  
 
Materials and Methods 
To generate the CRISPR lentiviral constructs bearing target sequences specific 
to the genomic locus of Wls, the following DNA techniques were used: restriction 
endonuclease-based cloning, gel extraction and PCR clean up, ligation and 
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transformation, DNA sequencing and preparation of plasmid DNA, albeit with minor 
variations. The lentiviral vector backbone was subjected to dephosphorylation using 
alkaline phosphatase (Fermentas) whilst undergoing restriction endonuclease 
digestion. The synthesized complementary target sequences were phosphorylated for 
30 minutes at 37 oC by T4 polynucleotide kinase (NEB) and 10X T4 ligation buffer 
(NEB), followed by being heated to 95 oC for 5 minutes and being cooled to 25 oC at 5 
oC/minute to facilitate annealing. A list of the target sequences used can be found in 
Appendix 1. After ligation, the plasmids constructs were transformed in Stbl3 
bacterial strains.  
The cell culture techniques used in this chapter include: cell culture and 
transient DNA transfection (specific for mammalian cell lines). The protein 
techniques used in this chapter include: lysate preparation from cultured cells, 
analysis of protein samples, BCA protein estimation assay and Western transfer and 
immunoblotting. Other experimental techniques used include: luciferase assay, 
mCherry fluorescence assay and lactate dehydrogenase (LDH) cell cytotoxicity assay. 
 
Lentiviral Production & Transduction 
To stably transduce HT1080 cell lines with the lentiviral CRISPR DNA, the 
lentiviral particles were first produced in the HEK293 FT mammalian cell line 
according to protocols found on Addgene (www.addgene.org/lentiviral/protocols-
resources). Briefly, HEK293FT cells were plated in 6-well plates and transfected with 
equal amounts of individual lentiviral CRISPR, plasmids, a packaging plasmid and an 
envelope plasmid. Seventy-two hours after transfection, the supernatant media 
containing the lentiviral particles was collected and filtered using a 0.45um filter to 
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trap cell debris. The filtered supernatant was then used to transduce HT1080 cells in 
the presence of Polybrene® (Sigma) to increase the infection. After incubating 
HT1080 cells with the lentiviral particles for forty-eight hours for infection, the cells 
were subjected to puromycin selection for five days to select for stably transduced 
cells. These transduced cells were then plated extremely low densities to facilitate 
single-cell colony formation and selection. 
Genomic DNA Extraction 
Genomic DNA was isolated from HT1080 cells using Qiagen DNeasy kits 
according to manufacturer’s instructions. Briefly, the cells were rinsed and 
resuspended in PBS, and proteinase K was added. Following the addition of buffer 
AL, the samples were incubated at 56 oC for 10 minutes. One volume of 100% 
ethanol was added to the lysates prior to loading into a DNeasy mini column. The 
column was washed once with buffer AW1 and once with buffer AW2 (containing 
ethanol). High-speed centrifugation was performed to dry the column, and DNA was 
eluted with nuclease-free water. DNA concentration was determined by NanoDrop 
2000 spectrometry (Thermo Scientific).  
Cel-1 Assay 
The ‘cutting efficiency’ of the various target constructs in facilitating genomic 
alterations via Cas9-mediated genomic cleavage was assessed using the Cel-1 assay. 
PCR reactions were carried out to amplify the targeted portion of genomic DNA from 
both wildtype and cells that had undergone puromycin selection in a thermal cycler 
(Bio-rad) using Platinum® Taq DNA polymerase High Fidelity (Invitrogen) and Cel-
1 primers (listed in Appendix 1). After performing PCR clean up on the samples, 
equal amounts of wildtype and mutated DNA fragments were mixed and annealed by 
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being heated to 95oC for 10 minutes and being cooled to 25oC at 0.3oC/second. The 
annealed DNA homoduplexes/heteroduplexes were subjected to Cel-1 nuclease 
cleavage at 42oC for 1 hour, and the resultant digested DNA fragments were run on a 
10% TBE polyacrylamide gel for analysis.   
Direct lysis of cultured cells 
The methodology described in the subsequent sections has been adapted from 
Dr. Li Shang’s laboratory protocols (Dr. Khairul, personal communication). 
Individual colonies were picked from 10-cm dishes plated with puromycin-selected 
transduced HT1080 cells and transferred to 96-well plates and maintained. When cells 
in the 96-well plate reached about 80% confluence, direct lysis was carried out using 
0.5x Direct-Lyse buffer (10 mM Tris pH 8.0, 2.5 mM EDTA, 0.2 M NaCl, 0.15% 
SDS, 0.3% Tween-20). Cells were rinsed with PBS and were trypsinized with 0.05% 
trypsin-EDTA (without phenol red) for 7 minutes. Approximately 5 μl of the cell 
suspension were added to 10 μl of Direct-Lyse lysis buffer in a 96-well PCR plate. 
The cell lysates were subjected to a series of heating and cooling steps to ensure 
complete lysis: 65°C for 30s, 8°C for 30s, 65°C for 1.5 min, 97°C for 3 min, 8°C for 1 
min, 65°C for 3 min, 97°C for 1 min, 65°C for 1 min, and 80°C for 10 min. The 
lysates were then diluted with 40 μl of water and subjected to PCR analyses. 
Fluorescent PCR 
The diluted lysates were used to amplify regions spanning the chosen targeting 
sequence in a high-throughput, 96-well format to identify clones harbouring indel 
mutations. PCR was carried out using Platinum Taq DNA Polymerase (Life 
Technologies) using primer pairs with 5’ modification on the forward primers 
(Appendix 1). HEX-labelled forward primers were used for lysates of parental 
wildtype HT1080 cells, whereas 6-FAM-labeled primers were used for lysates of 
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CRISPR/Cas9-targeted clones. The labeled amplicons were resolved on a 1% agarose 
gel to estimate their relative amounts to determine the appropriate dilution factor 
(typically 30-fold) for capillary gel electrophoresis analysis.  
Capillary gel electrophoresis 
Diluted fluorescent amplicons from wildtype and targeted cells were mixed in 
a 1:1 ratio, and 1 μl of this mixture was added to 8.7 μl Hi-Di Formamide and 0.3 μl 
GeneScan 500 LIZ dye Size Standard (Life Technologies) on a 96-well plate. As per 
manufacturer’s instructions, the resultant mixture was heated at 95°C for 3 minutes 
and subsequently cooled on ice for 3 minutes. These samples were resolved via 
capillary gel electrophoresis on a 3500xL Gene Analyzer (Life Technologies) and 
results were analyzed using Gene Mapper 5 software (Life Technologies). The 
magnitude of insertions or deletions of nucleotides at corresponding CRISPR/Cas9 
cleavage sites were estimated by calculating differences in fragment sizes. 
Results 
 
Three targeting guides exhibit high ‘cutting’ efficiency 
 We cloned 10 guides into the CRISPR/Cas9 lentiviral back bone: 6 guides 
targeting the 5’UTR of Wls and 4 guides targeting the boundary between the 5’UTR 
and the first exon of Wls. This targeting strategy was employed to ensure the earliest 
possible genomic disruption in the Wls locus so as to ablate the expression of 
endogenous Wls without adversely affecting transfected Wls mutant constructs 
(lacking the 5’UTR region targeted by the guides), as the stably-transduced HT1080 
cells would be constitutively expressing Cas9 and the targeting guide. Upon carrying 
out the Cel-1 assay, we observed significant variations in the cutting efficiency of the 
targeting guides (Fig. 7a). We decided to assess the ability of the targeting guides to 
disrupt proper gene transcription and trigger nonsense-mediated decay at the Wls 
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mRNA level via RT-PCR by activating nonsense-mediated decay of faulty mRNA, 
thereby most certainly ablating Wls protein expression. Based on this stringent 
criterion, we shortlisted three guides on their ability to facilitate decreased mRNA 
expression of both isoforms of Wls (Fig. 7b). We also investigated the Wnt secretion 
capacity of the stably transduced HT1080 cell populations expressing these shortlisted 
guides (Fig. 7c). Transfecting a small amount of wildtype Wls resulted in the rescue 
of the diminished Wnt secretion phenotype of these cell populations, thereby 
confirming the specificity of these guides in targeting the endogenous Wls genomic 
locus (Fig. 7c).  
 
Figure 7a: The diagram preceding the Cel-1 assay gel images is a schematic 
representation of the Wls gene locus (exons are numerically-labeled), and the 
arrow pointing downwards indicates the targeting region of the guides 
employed to disrupt the Wls locus. The Cel-1 PCR primers are also indicated in 
the diagram as mutually opposing arrows. The Cel-1 PCR gel illustrates the 
purified amplified products obtained upon specifically amplifying the targeted 
genomic locus of Wls in stably transduced HT1080 cells. Based on the 
corresponding Cel-1 assay gel, it can be concluded that almost all the targeting 
guides are causing genomic disruption in our desired locus, except the 5’UTR-
Exon1 guide G9. Hence, it is difficult to identify the most effective targeting guides 
from the results of this assay.  
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Figure 7b: The diagram preceding the RT-PCR analysis is a schematic 
representation of the two mammalian isoforms of Wls (Wls and Wlsv2, exons 
are numerically-labeled). The RT-PCR primers are also indicated in the diagram 
as mutually opposing black arrows. The RT-PCR analysis indicates that 5’UTR-
Exon1 guide G3, 5’UTR-Exon1 guide G9 and 5’UTR guide G2 (indicated with red 
arrows) are most likely causing nonsense-mediated decay (NMD) of the mRNA of 
both Wls isoforms. Albeit a considered more stringent criteria, the QPCR analysis 
of mRNA abundance of Wls version 1 (Wls V1) and Wls version 2 (Wls V2) 
facilitates the selection of stably-transduced HT1080 cell populations expressing 




Figure 7c: TOPFLASH assay of stably transduced HT1080 cell populations 
expressing the 3 most effective guides selected based on the QPCR analysis in 
Fig.7b. Compared to wildtype HT1080 cells (WT), the stably-transduced HT1080 
exhibit lower Wnt signaling activity that is specifically rescued by the transfection 
of a small amount of wildtype Wls. 
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First round clonal selection yielded colonies heterozygous for Wls 
 We expanded the cell populations of the three shortlisted guides and carried 
out serial dilutions and colony picking to isolate twenty-two clonal populations 
originating from single cells. The resultant clones were first screened for impairment 
in Wnt secretion via the TOPFLASH assay (Fig. 7d). Further characterization of Wls 
mRNA expression via RT-PCR (Fig. 7e) and Wls protein expression via Western 
immunoblotting (Fig. 7f) was carried out on clones that exhibited impaired Wnt 
signaling. To our dismay, the clones all showed relatively comparable Wls protein 
expression compared to wildtype HT1080 cells (Fig. 7g). To further assess the Wnt 
secretion capacity of these clones, we subjected them to the TOPFLASH assay in the 
presence and absence of exogenous wildtype Wls. We failed to obtain complete 
ablation of Wnt secretion in all clones except clone #1(Fig. 7h).  
This conundrum was elegantly solved when we carried out capillary 
electrophoresis analysis on these clones, and discovered that all the clones we had 
selected were heterozygous for Wls (one allele being wildtype Wls and the other 
allele possessing varied deletions in the Wls genomic locus). These results elude to 
Wls haplosufficiency in HT1080 cells. Due to the ease of genomic screening using 
capillary electrophoresis, we decided to modify our workflow accordingly to 







Figure 7d: TOPFLASH assay of 22 clonal HT1080 cell populations. Compared 
to wildtype HT1080 cells (WT), some clones exhibit lower Wnt signaling activity 




Figure 7e: RT-PCR analysis of selected clonal HT1080 populations that 
exhibited diminished Wnt signaling. Based on this analysis, it can be concluded 




Figure 7f: Immunoblotting analysis comparing the expression of endogenous 
Wls in wildtype HT1080 cells (WT) and selected clonal HT1080 populations 
that exhibited diminished Wnt signaling. The results of replicates of this assay 




Figure 7g: Quantification and comparison of endogenous Wls expression 
wildtype Wls and selected clonal HT1080 populations that exhibited 
diminished Wnt signaling (n=3). Only clone #1 shows some ablation in 
endogenous Wls expression, indicating that that Wls protein expression has not 
been ablated in most clones. 
 
 
Figure 7h: TOPFLASH assay of selected clonal cell populations compared 
wildtype HT1080 (solid bars), with a corresponding rescue of 50ng of 
exogenous wildtype Wls (shaded bars) for each population. Most clonal 
populations are exhibiting comparable Wnt signaling to wildtype HT1080 cells, 
except clone #1.  
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Putative homozygous Wls knockout clones have been identified via capillary 
electrophoresis 
 In view of the efficiency of capillary electrophoresis in identifying lesions in 
the endogenous Wls genomic locus, we decided to adopt the new workflow illustrated 
in Figure 7i. We picked 96 single-cell clones for screening by capillary 
electrophoresis, and analyzed the data to determine whether the clones were of single-
cell origin and their corresponding genotypes. To date, we have obtained 
approximately 11 putative homozygous Wls knockout clones and 17 putative 
heterozygous Wls clones based on capillary electrophoresis analysis. These results 
indicate the relatively high efficiency of the lentiviral CRISPR/Cas9 system in 
inducing specific genomic lesions in HT1080 cells. These candidate clones are 
currently undergoing expansion for further phenotypic characterization via Western 
immunoblotting, RT-PCR and Wnt secretion TOPFLASH assays.    
 
Figure 7i: Schematic representation of modified workflow to accelerate the 
screening HT1080 Wls knockout clones via capillary electrophoresis (adapted 
from Dr. Mohammed Khairul and Dr. Li Shang 2015, personal communication). 
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Summary and Future Directions 
 The CRISPR/Cas9 system has significantly improved the cumbersome 
endeavor of genomic engineering. Combining the lentiviral transduction system with 
capillary electrophoresis greatly accelerates the selection and screening of clones 
bearing the desired genomic lesions. We have employed these approaches in tandem 
to engineer a HT1080 Wls knockout cell line so as to elucidate the phenotypic 
consequences of this genomic lesion on cancer cell lines. We seek to repeat this 
procedure in other cancer cell lines such as the RKO colon cancer cell line and 
examine the phenotypic differences of knocking out Wls in various cell types. Doing 
so will yield new insights into the role of Wls not only in the context of Wnt secretion 
but also other aspects of cell morphology and biology.   
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CHAPTER 8: Investigating the role of monoubiquitination in the 
regulation of Wls 
 
Introduction  
 Although the intracellular trafficking of Wls has been relatively well 
characterized, the mechanisms by which these processes are regulated remain poorly 
understood. In particular, the exact biochemical signal by which Wls undergoes 
endocytosis remains elusive. Several receptors in various signaling cascades have 
been shown to undergo monoubiquitination, which in turn facilitates their 
endocytosis(Fukuda et al., 2012; Haglund et al., 2003).  
Unlike poly-ubiquitination, which often occurs as a mandatory pre-requisite to 
proteosomal degradation, monoubiquitination has been shown to play a regulatory 
role in a variety of cellular processes, including signaling activation, DNA damage 
repair, protein trafficking and receptor endocytosis(Yang et al., 2010). According to 
proteome analysis data available on PhosphoSite® (http://www.phosphosite.org), Wls 
is predicted to undergo ubiquitination (Kim et al., 2011; Wagner et al., 2011). 
Therefore, we proceeded to investigate if Wls indeed undergoes ubiquitination, and 
determine the putative residues on Wls that may be undergoing this crucial 
modification. We also attempted to dissect the role of this chemical modification on 
Wls in the context of the Wnt secretion pathway.  
 
Materials and Methods 
 
The DNA techniques used in this chapter described in Chapter 2 include: 
QuikChangeTM site-directed mutagenesis, DNA sequencing and preparation of 
plasmid DNA. The primers used to generate the Wls ubiquitination-resistant mutant 
constructs can be found in Appendix 1. The cell culture techniques used in this 
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chapter include:  cell culture, transient DNA transfection and siRNA transfection 
(specific for mammalian cell lines). The protein techniques used in this chapter 
include: lysate preparation from cultured cells, analysis of protein samples, BCA 
protein estimation assay, immunoprecipitation and Western transfer and 
immunoblotting. Other experimental techniques used include: immunofluorescence 
microscopy, luciferase assay, mCherry fluorescence assay and lactate dehydrogenase 
(LDH) cell cytotoxicity assay. 
Results 
 
Wls undergoes monoubiquitination  
To verify the PhosphoSite® data, we tested if Wls undergoes ubiquitination in 
vitro. We observed that Wls was detected using the experimentally verified 
monoclonal mouse antibody YJ5 upon immunoprecipitating HA-tagged ubiquitin as 
well as His-tagged ubiquitin, thus ruling out the possibility of experimental artifacts 
(Fig. 8a).  Furthermore, the immunoprecipitated Wls was detected at the same 
molecular weight as wildtype Wls, and this observation is suggestive of 
monoubiquitination instead of poly-ubiquitination for proteasomal degradation. To 
check if Wls undergoes other similar atypical regulatory modifications(Ikeda and 
Dikic, 2008), we repeated the experiment with constructs expressing other small 
proteins such as Sumo1, Sumo2, Sumo3, Atg8, misg15 and NEDD8. Again, Wls was 
detected specifically when immunoprecipitated with HA-tagged ubiquitin (Fig. 8b). 








Figure 8a: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls and HA-tagged ubiquitin (RHS panel) or His-tagged ubiquitin 
(LHS panel). In both instances, a faint Wls band is observed upon 
immunoprecipitating the epitope ubiquitin is bound to. The molecular weight of this 




Figure 8b: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls and HA/myc-tagged ubiquitin and other atypical small 




K410 is the putative residue on Wls undergoing monoubiquitination 
We carried out site-directed mutagenesis on the putative ubiquitination sites as 
predicted by Phosphosite®. We mutated the lysine residues to arginine as this 
mutation renders the residues ubiquitination-resistant whilst maintaining the 
associated positive charge and thereby preserving the protein’s secondary 
structure(Fukuda et al., 2012). We found that mutating the highly conserved residue 
K410 results in the abrogation of the monoubiquitinated Wls signal. In contrast, 
mutating the less conserved K419 residue did not result in the reduction of 
monoubiquitination observed in Wls. This abrogation effect was also observed in the 
Wls K410R K419R double mutant (Fig.8c). Upon examining the predicted Protter 
structure of Wls (Fig. 8d), it can be concluded that these two residues are found in the 
3rd intracellular loop of Wls, thereby rendering them accessible for intracellular 
monoubiquitination.  We hence hypothesized that Wls is most probably 
monoubiquitinated at the lysine residue K410, and this modification facilitates the 
endocyotosis of Wls.  
 
Figure 8c: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls and Wls ubiquitination-resistant mutants and HA-tagged 
ubiquitin. The intensity of the putative Wls monoubiquitination is reduced in both 




Figure 8d: Predicted topology of Wls by Protter (http://wlab.ethz.ch/protter/). 
The putative lysine residues that may undergo mono-ubiquitination are 
located a predicted cytoplasmic loop of Wls. 
 
Mutating K410 may adversely interfere with the YEGL endocytosis motif  
 We further investigated the subcellular localization of wildtype Wls and the 
ubquitination-resistant Wls mutants. To our surprise, the mutant Wls K410R 
exhibited a plasma membrane-bound localization phenotype that was similar to the 
previously published Wls mutant Y425A (Gasnereau et al., 2011)(Fig.8e).Both Wls 
K410R and  Wls Y425A exhibit similar subcellular localization, diminished Wnt 
signaling activity and monoubiquitination signal compared to wildtype Wls (Fig. 8f, 
8g, 8h). Sequence alignment of Wls across various species indicates that the residue 
K410 is comparable in its degree of conservation as the key tyrosine residue in the 
putative endocytosis motif of Wls. Thus, the possibility that mutating K410 adversely 





Figure 8e: Comparing the subcellular localization of Wls ubiquitination-
resistant mutants with wildtype Wls through immunofluorescence staining and 
confocal microscopy. Wls K410R and Wls K410R K419R are localized primarily 
at the plasma membrane; a phenotype which closely resembles a previously 
characterized Wls endocytosis mutant Wls Y425A.  
 
 
(clockwise) Figure 8f: Comparing the subcellular localization of Wls K410R 
and Wls Y425A with wildtype Wls through immunofluorescence staining and 
confocal microscopy. Both mutants exhibits similar plasma membrane-bound 
subcellular localization.  
Figure 8g: TOPFLASH assay of wildtype Wls and K410R and Wls Y425A 
(5ng, 10ng and 20ng of Wls plasmids transfected sequentially per Wls 
construct) carried out in cells expressing a Wnt-responsive luciferase reporter. 
Both mutants exhibit diminished Wnt signaling compared to wildtype Wls. 
Figure 8h: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls, Wls K410R and Wls Y425A and HA-tagged ubiquitin. The 
intensity of the putative Wls mono-ubiquitination is reduced in both Wls K410R 
and Wls Y425A. 
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Figure 8i: Sequence alignment of Wls across several species indicates that the 
proposed endocytosis YEGL motif is highly conserved (Gasnereau et al., 2011). 
K410 is located in close proximity to this motif, and is also very highly conserved.  
 
Wls may be binding to another monoubiquitinated protein 
 We tried repeatedly to isolate the elusive endogenously monoubiquitinated 
species of Wls from HeLa cells, which have relatively high levels of endogenous Wls. 
However, even upon immunoprecipitating 2000ug of total protein from HeLa cells 
transfected with HA-tagged ubiquitin, we were unable to detect the characteristic 
‘monoubiquitinated’ Wls band that was consistently detected in all our previous Wls 
over-expression studies. Treating HEK293 cells co-transfected with Wls and Ha-
tagged ubiquitin with the proteaosomal degradation inhibitor MG132 results in an 
increased Wls ubiquitination signal (Fig. 8i), suggesting that over-expression may be 
contributing to this phenomenon. These observations directly contravene our 
hypothesis of Wls being monoubiquitinated as a form of regulation rather than for 
proteosomal degradation. Moreover, immunoprecipitating Wls and staining with HA-
specific or His-specific antibodies indicates the presence of several high molecular 
weight bands (Fig.8k), indicating that Wls may be binding other proteins/protein 




Figure 8j: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls and HA-tagged ubiquitin, treated with either DMSO or MG132. 
The intensity of the putative Wls monoubiquitination band increases upon MG132 
treatment (treatment duration=6 hours), suggesting that Wls may be undergoing 
ubiquitination for proteosomal degradation.  
 
 
Figure 8k: Immunoprecipitation analysis of HEK293 cells co-transfected with 
wildtype Wls and HA-tagged ubiquitin (RHS panel) or His-tagged ubiquitin 
(LHS panel). In both instances, several high molecular weight bands are observed, 





Summary and Future Directions 
 The monoubiquitination of Wls remains a tantalizing yet controversial 
phenomenon. Over-expression immunoprecipitation studies indicate the occurrence of 
monoubiquitination as a specific modification on Wls. The highly conserved K410 
residue in the 3rd intracellular loop of Wls is a likely candidate undergoing 
monoubiquitination, as evidenced by diminished monoubiquitination signal and the 
plasma membrane localization of the Wls K410R mutant.  
However, the proximity of this key residue to the proposed YEGL endocytosis 
motif of Wls may be contributing to the aberrant localization of Wls 
K410R.Furthermore, we were unable to detect Wls monoubiquitination in the 
endogenous context of HeLa cells, and we cannot exclude the possibility of the Wls 
ubiquitination phenomenon being a result of protein over-expression. The subsequent 
increase in monoubiquitination observed upon MG132 treatment also supports this 
hypothesis. It is possible that Wls is not directly monoubiquitinated, but is instead part 
of a protein complex that undergoes ubiquitination.  
A decisive way to determine if Wls is directly mono-ubiquitinated is to carry 
out mass spectrometry on purified Wls to determine the exact nature of post-
translational modifications it is subjected to. The internally tagged 3XFLAG Wls 
described in chapter 6 is ideal for this purpose. If Wls is indeed found to be 
monoubiquitinated, an extensive ‘lysine scan’ can be carried out whereby all 
candidate lysine residues are mutated to arginines sequentially to overcome 
redundancy and identify the key lysine residues involved, thereby shedding light on 
the mechanistic basis of ubiquitination mode of Wls regulation in Wnt signaling.  
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CHAPTER 9: Conclusions & Future Directions 
 
 The overarching aim of the experiments described thus far was to extensively 
characterize the biochemical mechanisms governing the regulation of Wls as well as 
the binding and release of Wnts from Wls in the Wnt secretion pathway. To achieve 
this central goal, we employed a plethora of biochemical assays and imaging 
techniques, as well as used cutting-edge technologies such as CRISPR/Cas9 genomic 
engineering. Below is a list of our key findings and corresponding future directions: 
 Based on our laboratory’s characterization of the retrograde transport of Wls in 
mammalian cells, we investigated the subcellular localization of the Wls homolog 
Evi in S2 Drosophila cells using techniques similar to those used in mammalian 
cells. However, our multiple attempts using the S2 cell lines obtained from other 
laboratories were thwarted by mycoplasma contamination. The methods described 
in Chapter 3 can be used on a contamination-free S2 Drosophila cell line to 
determine whether the retrograde transport of Wls is an evolutionarily conserved 
phenomenon, or if it is unique to mammalian cells. 
 
 We identified candidate highly-conserved hydrophobic residues in the putative 
Wnt-binding region of Wls that might be involved in binding Wnts in the Wnt 
secretion pathway. The residues C50, C71 and L196, along with the key residue 
W106 which exhibited significantly lower binding affinity compared to wildtype 
Wls, may be acting in tandem to stabilize the interaction between Wls and the 
hydrophobic Wnt3a palmitoyl tail.  The binding affinity and Wnt secretion 
capacity of Wls mutants bearing multiple mutations in these hydrophobic residues 
can be further assessed to determine the exact mechanism of Wnt-Wls binding. 
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 Wls may possess ‘pH-sensing’ capacity that facilitates the dissociation of bound 
Wnt3a, as mutating the highly-conserved histidine residues H192 and H496 to 
glutamine resulted in higher binding affinity to Wnt3a and the impairment of Wnt 
secretion. The intracellular retention of candidate pHluorin2-tagged Wnts was 
occured upon bafilomycin treatment, thereby underscoring the importance of the 
pH gradient in Wnt secretion. However, bafilomycin treatment did not uniformly 
impede the secretion of all 19 mammalian Wnts, and differential Wnt extracellular 
secretion patterns were observed in HEK293 cells. Furthermore, extracellular 
accumulation of Wnts was not detected in both HeLa cells and HT1080 cells. 
Further investigation into the role of intracellular pH changes in Wnt secretion is 
warranted , and our current observations regarding Wnt extracellular secretion 
patterns seems to support the nascent cytoneme model of  Wnt ligand transport. 
 
 Mass spectrometric proteome analysis from our collaborators identified potential 
novel interacting partners of Wls, none of which turned out to be bona fide 
regulators of Wls in the context of Wnt secretion. Hence, we have generated a 
partially-viable Wls-BirA fusion construct as well as a viable internally-tagged 
3XFLAG Wls; the latter being amenable to protein over-expression and FLAG 
immunoprecipitation and thus suitable for identifying potential interacting 
proteins by mass spectrometry. Both Wls constructs can be cloned into adenoviral 
backbones to facilitate massive over-expression so as to pull down low abundance 





 Our venture of generating a Wls knockout HT1080 cell line using CRISPR/Cas9 
genome engineering technology has been fraught with several technical and 
biological challenges that are particular to the HT1080 cell line. Hence, we will 
use our optimized lentiviral guide constructs in other candidate cancer cell lines 
(eg: RKO cell line) along with capillary electrophoresis of single-cell clones to aid 
rapid genotyping and screening of Wls heterozygous and homozygous knockout 
clones. These clones will be subjected to extensive biochemical characterization 




 Preliminary co-immuprecipitation studies indicate that Wls may be undergoing 
monoubiquitination on the highly-conserved K410 residue, or might be binding to 
another unknown monoubiquitinated protein. The regulatory role of this post-
translational modification or interaction remains to be fully characterized. Mass 
spectrometric analysis of purified internally-tagged 3XFLAG Wls will 
conclusively identify post-translational modifications of Wls for further 
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ID Primer Name Primer Sequence 
SAK1 
SAK2 
WLS K410R F 





WLS K419R F 






WLS K497R F 





WLS Age1 site G464 F 





WLS H57Q H58Q F 





WLS H70Q F 





WLS H95Q F 





WLS H100Q F 





WLS H153Q F 





WLS H192Q F 





WLS H225Q F 





WLS H172Q F 





WLS H459Q F 







WLS H322Q F 





WLS H327Q F 





WLS H331Q F 





WLS H424Q F 





WLS H496Q F 





WLS H511Q F 





WLS H524Q F 





WLS C50A F 





WLS W62A F 





WLS C71A F 





WLS V91A F 





WLS W106A F 





WLS W148A F 





WLS L160A F 





WLS C162A F 





WLS C179A F 





WLS L196A F 
WLS L196A R 
CATAAGTTTTACGCTTTAAACATCC 




Evi Untagged F 
Evi Untagged R 




Evi aa1-589 F 





Evi K590R F 





Evi K590A F 







WLS Forward GCCATGGCTGGGGCAATT 
WLS Reverse CTCCTGGGCCTCCTTGCG 
myc-tagged BirA Forward ACCGGTGACAAGGACAACACC 
myc-tagged BirA Reverse ACCGGTGCCTCCTCCCTTCTCTGCGCTTCTC 
pHluorin2 Forward ACCGGTGTGAGCAAGGGCGAGGAG 
pHluorin2 Reverse ACCGGTGCCTCCTCCCTTGTACAGCTCGTCC 
 
qPCR primer sequences (for human genomic DNA) 
 
WLS 1688 Forward CAGTCCAAGTGAACAGTGCC 
WLS Reverse CTCCTGGGCCTCCTTGCG 
WLSv2 Reverse CTAAATACCAGAAGCTGCGTTGTC 
Wls Exon1 Forward GTGGGAGGCTTGATTGCTCC 
Wls Exon1 Reverse TGCCTCTTCAATGTCTCGGA 
ATP2A1 Forward TCTGGAGAAATACGGCCTCA 
ATP2A1 Reverse AGGCCAGCACGAAGGAAATG 
DERL1 Forward GATCACGCGCTATTGGTTCG 
DERL1 Reverse GGCCTCCAAATCTGAAAGCGA 
RAB5A Forward ACGGGCCAAATACGGGAAAT 
RAB5A Reverse AGAAAAGCAGCCCCAATGGT 
HPRT Forward CTCCGTTATGGCGACCC 
HPRT Reverse CACCCTTTCCAAATCCTCAG 
 
 110 
siRNA targeting sequences & dsRNA synthesis primers 
 
siWLS #5 ACGAATCCCTTCTACAGTA  
Evi 344bp Forward  TAATACGACTCACTATAGGGATTCTGTGCAT
TCGACAACG 
Evi 433bp Forward  TAATACGACTCACTATAGGGTGAGATCACA
ATTTGGCCTG 
Evi 344bp and 





Wls CRISPR targeting guide sequences 
 
Wls 5’UTR-Exon1 G#3 AGGGGGGGCGCAAAAATGGC 
Wls 5’UTR-Exon1 G#5 GGGGGGCGCAAAAATGGCTG 
Wls 5’UTR-Exon1 G#6 GGGGGGGCGCAAAAATGGCT 
Wls 5’UTR-Exon1 G#9 AAAAAGGGGGGGCGCAAAAA 
Wls 5’UTR G#1 CGCCGCCTGTGGACGCTTAA 
Wls 5’UTR G#2 TGCGCCGGGGGAATCCGTGC 
Wls 5’UTR G#3 CTGCTCCTTTAAGCGTCCAC 
Wls 5’UTR G#4 ACGGATTCCCCCGGCGCAGC 
Wls 5’UTR G#5 CTGCGCCGGGGGAATCCGTG 
Wls 5’UTR G#6 CGGGACGGAAGGCGCCCGCA 
 
Cel-1 Assay Primers 
 
Cel-1 Forward  GTGTTTTGACTTAGGCATCTATTGGG 
 
Cel-1 Reverse  CAAGAGGCAAAGAGGGAAGGGGCCCG 
 
 
Capillary Electrophoresis Primers 
 
Fluroscent Forward primer 




Fluroscent Forward primer 




Reverse primer for Wls 
CRISPR locus and wildtype 
Wls 
TCATAGAAGCAAGGCAGTGATAC 
 
 
